Optical Modalities for Assessing the Microcirculation in Hypovolemia and Anemia by Bartels, S.A. (Sebastiaan)
OPTICAL MODALITIES FOR ASSESSING  
THE MICROCIRCULATION IN HYPOVOLEMIA AND ANEMIA
S.A. Bartels

It all depends on how we look at things, and not how they are in themselves.
Carl Jung

Dedicated to my parents, Niels, Maartje, and Marije
The Department of Intensive Care, 
Erasmus Medical Center,  
University of Rotterdam,  
Rotterdam, The Netherlands
The Department of Translational 
Physiology, Academic Medical Center, 
University of Amsterdam, Amsterdam, 
The Netherlands
The Department of Intensive Care, 
Medical Center Alkmaar, Alkmaar,  
The Netherlands
BMEYE,  
Amsterdam, The Netherlands
Research Foundation Oxygen 
Transport To Tissue,  
Leiden, The Netherlands
Printing of this thesis was kindly sponsored by: 
 
 
 
 
 
Research Foundation Oxygen Transport To 
Tissue, Leiden, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Erasmus 
Medical Center, University of Rotterdam, 
Rotterdam, The Netherlands 
 
 
 
 
The Department of Translational Physiology, 
Academic Medical Center, University of 
Amsterdam, Amsterdam, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Medical 
Center Alkmaar, Alkmaar, The Netherlands 
 
 
 
BMEYE, Amsterdam, The Netherlands 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN:  
 
Layout and printing: Off Page, www.offpage.nl 
 
Cover: Impression of red blood cells 
 
Cover design: P.C.M. Bartels, Heiloo, the Netherlands 
 
Copyright © Bastiaan Bartels, Amsterdam 2011. All rights reserved. No part of this 
publication may be reproduced, stored in a retrieval system, or transmitted in any form or by 
any means mechanically, by photocopy, by recording, or otherwise, without the prior written 
permission of the holder of copyright. 
Printing of this thesis was kindly sponsored by: 
 
 
 
 
 
Research Foundation Oxygen Transport To 
Tissue, Leiden, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Erasmus 
Medical Center, University of Rotterdam, 
Rotterdam, The Netherlands 
 
 
 
 
The Department of Translational Physiology, 
Academic Medical Center, University of 
Amsterdam, Amst rdam, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Medical 
Center Alkmaar, Alkmaar, The Netherlands 
 
 
 
BMEYE, Amsterdam, The Netherlands 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN:  
 
Layout and printing: Off Page, www.offpage.nl 
 
Cover: Impression of red blood cells 
 
Cover design: P.C.M. Bartels, Heiloo, the Netherlands 
 
Copyright © Bastiaan Bartels, Amsterdam 2011. All rights reserved. No part of this 
publication may be reproduced, stored in a retrieval system, or transmitted in any form or by 
any means mechanically, by photocopy, by recording, or otherwise, without the prior written 
permission of the holder of copyright. 
Printing of this thesis was kindly sponsored by: 
 
 
 
 
 
R search Fou dation Oxygen Transport To 
Tissue, Leiden, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Erasmus 
Medical Center, University of Rotterdam, 
Rotterdam, The Netherlands 
 
 
 
 
The Department of Translational Physiology, 
Academic Medical Center, University of 
Amsterdam, Amsterdam, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Medical 
Center Alkmaar, Alkmaar, The Netherlands 
 
 
 
BMEYE, Amsterdam, The Netherlands 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN:  
 
Layout and printing: Off Page, www.offpage.nl 
 
Cover: Impression of red blood cells 
 
Cover design: P.C.M. Bartels, Heiloo, the Netherlands 
 
Copyright © Bastiaan Bartels, Amsterdam 2011. All rights reserved. No part of this 
publication may be reproduced, stored in a retrieval system, or transmitted i  any form r by 
any means mechanically, by photocopy, by recording, or otherwise, without the prior written 
permission of the holder of copyright. 
Printing of this thesis was kindly sponsored by: 
 
 
 
 
 
Research Foundation Oxygen Transport To 
Tissue, Leiden, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Erasmus 
Medical Center, University of Rotterdam, 
Rotterdam, The Netherlands 
 
 
 
 
The Department of Translational Physiology, 
Academic Medical Center, University of 
Amsterdam, Amsterdam, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Medical 
Center Alkmaar, Alkmaar, The Netherlands 
 
 
 
BMEYE, Amsterdam, The Netherlands 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN:  
 
Layout and printing: Off Page, www.offpage.nl 
 
Cover: Impression of red blood cells 
 
Cover design: P.C.M. Bartels, Heiloo, the Netherlands 
 
Copyright © Bastiaan Bartels, Amsterdam 2011. All rights reserved. No part of this 
publication may be reproduced, stored in a retrieval system, or transmitted in any form or by 
any means mechanically, by photocopy, by recording, or otherwise, without the prior written 
permission of the holder of copyright. 
Printing of this thesis was kindly sponsored by: 
 
 
 
 
 
Research Foundation Oxygen Transport To 
Tissue, Leid n, The Netherlands 
 
 
 
 
 
Th  Department of Intensive Care, Erasmus 
Medical C nter, Univ sity of Rotterdam, 
Ro terdam, The Netherlands 
 
 
 
 
The Department of Translational Physiology, 
Academic Medical Center, University of 
Amsterdam, Amsterdam, The Netherlands 
 
 
 
 
 
The Department of Intensive Care, Medical 
Center Alkmaar, Alkmaar, The Netherlands 
 
 
 
BMEYE, Amsterdam, The Netherlands 
 
 
 
 
 
 
 
 
 
 
 
ISBN:  
 
Layout and printing: Off Page, www.offpage.nl 
 
Cover: Impression of red blood cells
 
Cover design: P.C.M. Bartels, Heiloo, the Netherlands 
 
Copyright © Bastiaan Bartels, Amsterdam 2011. All rights res rv d. No part of this 
publication may be reproduced, stored in a retrieval system, or transmitted in any form or by 
any means mechanically, by photocopy, by recording, or otherwise, without the prior written 
permission of the holder of copyright. 
Printing of this t esis was kindly sponsored by:
ISBN: 978-94-6182-071-6
Layout and printing: Off Page, www.offpage.nl
Cover: Impression of red blood cells
Cover design: P.C.M. Ba t ls, Heiloo, the Netherlands
Copyright © Bastiaan Bartels, Amsterdam 2011. All rights reserved. No 
part of this publication may be reproduced, stored in a retrieval system, 
o  transmit ed in any form or by any means mechanically, by photocopy, 
by recording, or otherwise, without the prior written permission of th  
holder of copyright.
OPTICAL MODALITIES FOR ASSESSING THE MICROCIRCULATION 
IN HYPOVOLEMIA AND ANEMIA
Optische modaliteiten voor de evaluatie van de microcirculatie  
in hypovolemie en anemie
Proefschrift
ter verkrijging van de graad van doctor aan de
Erasmus Universiteit Rotterdam
op gezag van de rector magnificus
Prof.dr. H.G. Schmidt
en volgens het besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op
 
door
Sebastianus Antonius Bartels
geboren te Oud en Nieuw Gastel
Optical Modalities for Assessing the Microcirculation in Hypovolemia and Anemia 
 
 
Optische modaliteiten voor de evaluatie van d  microcirculatie in hypovolemie en anemie 
 
 
Proefschrift 
 
ter verkrijging van de graad van doctor aan de 
Erasmus Universiteit Rotterdam 
op gezag van de rector magnificus 
Prof.dr. H.G. Schmidt 
 
en volgens het besluit van het College voor Promoties. 
 
 
De openbare verdediging zal plaatsvinden op 
 
 
Woensdag 7 maart 2012 om 9.30 Uur 
 
 
door 
 
 
Sebastianus Antonius Bartels 
 
geboren te Oud en Nieuw Gastel 
 
 
 
 
woensdag 7 maart 2012 om 9.30 uur
Promotiecommissie
Promotoren:  Prof.dr. J. Bakker
   Prof.dr.ir. C. Ince
Overige leden:  Prof.dr. D.J.G.M. Duncker
   Prof.dr. A.B.J. Groeneveld
   Prof.dr. M.J. Schultz
   
Co-promotor:   Dr. R. Bezemer
contents
 Introduction: The microcirculation – advancing insights 11
 Outline of the thesis 23
Chapter I Noninvasive cardiac output monitoring during exercise 
testing: pulse contour analysis compared to an inert gas  
rebreathing method and respired gas analysis 29
Chapter II Peripheral perfusion index as an early predictor for central 
hypovolemia 43
Chapter III The microcirculatory response to compensated hypovolemia 
in a lower body negative pressure model as studied using  
SDF imaging and NIRS 55
Chapter IV Multi-site and multi-depth near-infrared spectroscopy in 
a model of simulated (central) hypovolemia: lower body  
negative pressure 73
Chapter V Red blood cell transfusions and tissue oxygenation in 
anemic hematology outpatients 87
 
 Summary and Conclusions  99
 Samenvatting en Conclusies  105
 List of publications 111
 Acknowledgements 115
 Curriculum Vitae 121

R.Bezemer, S.A. Bartels, J. Bakker, C. Ince
Crit Care 2011 submitted in altered form
introduction 
the microcirculation – advancing insights
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introduction
The microcirculation, consisting of the vessels with a diameter < 100 µm,  is the 
most important system for the exchange of oxygen, carbon dioxide, and nutrients. 
The microcirculation plays a key role in the development of (multiple) organ 
failure in critically ill patients. The main aim of hemodynamic resuscitation in this 
patient group is to restore microcirculatory perfusion and tissue oxygenation to 
prevent organ hypoxia and maintain organ function [1-3]. It has been recognized 
that therapeutic interventions should be delivered as early as possible [3,4]. Early 
protocol-driven resuscitation strategies (e.g., early goal-directed therapy) targeting 
global hemodynamic parameters have been associated with superior clinical outcome 
in randomized controlled clinical trials [4,5]. However, even after interventions 
effectively optimizing macrocirculatory hemodynamics (e.g., cardiac filling pressure, 
cardiac output, blood pressure, and central or mixed venous oxygen saturation), 
high mortality rates still persist [6]. Rather than limiting research to macrocirculatory 
parameters, microcirculatory parameters should be incorporated to increase the 
pathophysiological knowledge underlying the disease states in these critically ill 
patients. Within this respect, it has been shown that improvement of macrocirculatory 
hemodynamics does not guarantee (sufficient) improvement of the microcirculation 
[2]. In this introduction we first provide a brief history of clinical monitoring of the 
microcirculation and we describe how microcirculatory parameters have been of great 
prognostic value in intensive care patients. Subsequently, we discuss the effects of 
resuscitation and blood transfusion on the microcirculation.  
Brief history of clinical imaging of the microcirculation
The role of blood in life has intrigued people as long as mankind exists. The classical 
concept of Galen involved two different types of blood and lasted for many centuries. 
Galen presumed that one type of blood was generated in the liver and this type was 
responsible for growth and energy delivery throughout the body. The other type of 
blood originated from the heart and took care of the transport of the spiritus vitalis, 
i.e. pneumatised blood, to the body tissues. The two types of blood had their own 
vessel architecture. Blood was directly consumed, resulting in a non-circulatory system 
according to Galen [7]. For a long time, the ideas of Galen remained undebated, 
until Ibn al-Nafis, Michael Servetus, and William Harvey challenged the classical Galen 
concepts. Ibn Al-Nafis reported the concept of circulation for the first time in the 13th 
century, yet limited the report to the pulmonary circulation [8]. In 1553 Michael Servetus 
published a description of closed circuit circulation in the human body [9]. However, 
this hypothesis led to prosecution of Servetus and omittance of his contribution to 
the ideas on the circulation of the human body. In 1628 William Harvey provided 
a major breakthrough by describing a closed circuit circualation and suggested in 
Exercitatio Anatomica de Motu Cordis et Sanguinis in Animalibus a direct connection 
between the arteries and veins in the entire human body [10]. Since Harvey could 
not observe such a connection, he used series of relatively simple experiments to 
proof the concept of a closed circulation and proposed the heart as driving force in 
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the circulation [7]. Whereas Harvey had to speculate on the existence of very small 
vessels or connections, this issue was clarified by the discovery of the capillary system 
by Marcello Malpighi [11]. Malpighi could directly observe the existence of capillaries 
in animals by application of microscopy, being regarded as the final evidence. Later, 
Antoni van Leeuwenhoek could observe in vivo capillary flow for the first time [12,13].
After Van Leeuwenhoek’s introduction of in vivo microcirculatory microscopy, the 
technique was long limited to semi-transparent tissue that could be transilluminated to 
avoid image contamination by tissue surface reflections and thereby obtain sufficient 
image contrast [14-16]. Later on, incident light directed at an oblique angle to the 
studied tissue has been applied [17]. Such a setup, however, did require very careful 
alignment of the light source and the microscopic lens system while it still suffered 
from tissue surface reflections. It was not until 1971 that Sherman et al. introduced 
a new method for studying the microcirculation: incident dark field illumination 
microscopy [18]. Dark field illumination was provided through a circular prismatic lens 
surrounding the objective lens which created a halo of light around and beyond the 
objective focal point. The method of illumination yielded “an unusual depth of field 
and a three-dimensional quality to the tissue observed” and permitted visualization 
of microcirculatory structures beneath the surface of organs as dark red blood cell 
columns on a bright background. The authors visualized and photographed the 
circulation of the cat brain, lung, kidney, liver, mesentery, and intestine successfully. 
In 1987, Slaaf et al. developed an alternative way of eliminating tissue surface 
reflections for imaging subsurface microcirculatory networks inspired by fluorescence 
microscopy [19]. In fluorescence microscopy, image contrast is created by spectral 
separation of the reflected illumination light and the imaging light by application of an 
excitation and an emission filter in combination with a dichroic mirror. Similarly, Slaaf 
et al. proposed to separate the reflected illumination light from the imaging light by 
application of a polarizer and an analyzer in combination with a fifty percent reflection 
mirror. Due to its orthogonal orientation with respect to the polarized illumination 
light, the analyzer blocked reflected (undepolarized) light and allowed back scattered 
(depolarized) light to pass. This setting provided images of the microcirculation with 
sufficient contrast, similar to those obtained using dark field imaging. 
Several years later, Groner et al., combined the methods developed by Sherman et 
al. and Slaaf et al. and added a spectral component for further optimization of image 
contrast. In 1999, they introduced orthogonal polarization spectral (OPS) imaging, 
incorporated into a hand-held, clinically-applicable device [20]. Using OPS imaging 
our group was the first to image the human brain microcirculation during surgery [20]. 
Since then, numerous studies have been undertaken in various clinical settings where 
cardiovascular function is at risk. 
Despite the major contribution OPS imaging has made in the field of intravital 
microcirculatory imaging, several shortcomings are still present [21,22]. These include 
suboptimal imaging of capillaries due to motion-induced image blurring by movement 
of the OPS device, the tissue, and flow of red blood cells. The shortcomings might 
introduce difficulties in measuring blood flow velocities in the vessels. Thus, driven by 
the success of OPS imaging and its drawbacks, Goedhart et al. developed a second 
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generation device for clinical imaging of the microcirculation, termed sidestream dark 
field (SDF) imaging [23]. To date, many studies have investigated the microcirculation 
using OPS and SDF imaging under various pathophysiological conditions such as in 
surgery, emergency medicine, and intensive care medicine. Both OPS and SDF imaging 
have had an important clinical impact by observation of the sublingual microcirculation 
under various pathophysiological conditions, particularly during sepsis and shock [1-3]. 
Results from several medical studies have shown that alterations in the sublingual 
microcirculation provide more sensitive information with respect to patient outcome 
from sepsis and shock than conventional clinical parameters do.
In parallel to the progress in the field of microcirculatory imaging, alternative 
methods have been developed for the assessment of microcirculatory perfusion and 
oxygenation. Jobsis introduced near-infrared spectroscopy (NIRS) in 1977 [24], which 
assesses hemoglobin oxygen saturation in the microvasculature of tissue. In 1985, 
Ferrari et al. published the first clinical NIRS results [25] and afterwards many studies 
followed. The NIRS technique emits light at different wavelengths, corresponding 
to the absorption spectra of oxyhemoglobin, deoxyhemoglobin, methemoglobin, 
and cytochrome. The device determines the oxygen saturation in a certain amount 
of tissue volume, influenced by probe spacing, adiposity, and edema. Under 
normal physiological conditions, ~70 % of the blood volume derives from venous 
compartments. Clinically, NIRS was mainly used to monitor cerebral oxygenation in 
adults and children [26-28]. However, the results of NIRS in order to predict the effect 
of blood transfusion [29], identify shock [30], and critically ill patients have also been 
investigated [31]. 
Nevertheless, the role of application site and different commercially available 
devices currently limit the interpretation of the NIRS-derived results. Furthermore, 
NIRS does not take the role of blood flow into account, so interpretation of the results 
remains complicated. Several solutions, such as different probing depths and vascular 
occlusion tests, have been proposed to improve the sensitivity of NIRS in critically ill 
patients and healthy volunteers [32,33]. 
Prognostic value of the microcirculation
Microcirculatory failure is of significant prognostic value. Microcirculatory disorders 
before resuscitation and the persistence after resuscitation have been associated 
with increased risk of morbidity and mortality [1-3,34,35]. De Backer et al. found that 
microcirculatory alterations in non-surviving ICU patients were more severe compared 
to those in surviving patients [1]. This observation was later confirmed by Sakr et al. 
and Trzeciak et al. Furthermore, these studies showed that a lack of improvement 
of microcirculatory flow after resuscitation was associated with organ failure and 
death [2] and that non-surviving patients had significantly increased microcirculatory 
flow heterogeneity compared to surviving patients [3]. Doerschug et al. found that 
impairments in microvascular reactivity in ICU patients were related to organ failure 
[33]. In a later study, Trzeciak et al. demonstrated that early increases in microcirculatory 
perfusion during protocol-directed resuscitation were associated with reduced 
multiple organ failure in ICU patients [35]. Lima et al., furthermore, found that ICU 
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patients who consistently exhibited low microcirculatory oxygenation levels following 
an initial resuscitation had significantly worse organ failure in comparison with patients 
with normal microcirculatory oxygenation [36]. They demonstrated that oxygenation 
changes had no relationship with global hemodynamic variables. Besides in ICU 
patients, microcirculatory disorders predict mortality in patients with acute severe 
heart failure and cardiogenic shock [37]. Furthermore, impaired microvascular flow was 
associated with post-operative complications in patients with major abdominal surgery 
[38]. Hence, a growing body of evidence underlines the hypothesis implicating that 
depressed microcirculatory function can be considered as a key cause of morbidity 
and mortality in a wide array of clinical scenarios.
resuscitation of the microcirculation
In their key study, Rivers et al. described an early goal-directed therapeutic protocol 
in which fluid resuscitation was performed untill central venous pressure was 8-12 
mmHg, vasopressor agents were added to maintain the mean arterial pressure 
above 65 mmHg. Red blood cell transfusions and/or inotropic agents were used to 
increase central venous oxygen saturation to above 70 % [4]. With application of this 
protocol, Rivers et al significantly reduced the mortality rate in critically ill patients 
(31 % versus 47 % for standard therapy). Later on, Jansen et al. developed a lactate-
targeted treatment protocol with the aim of preventing and treating tissue hypoxia. 
The protocol incorporated the vasodilators nitroglycerin and ketanserin for correction 
of microcirculatory derangements, the inotropes dobutamin and enoximone for 
correction of myocardial dysfunction, and fluids and blood transfusions for correction 
of hypovolemia and anemia [39]. Surprisingly, the treatment algorithm did not result 
in faster reduction of lactate compared to the control group, but it did significantly 
reduce hospital mortality. This observation demonstrates that volume replacement 
therapy using fluids and/or blood in combination with vasoactive agents to modulate 
microvascular perfusion is essential for resuscitation of severely ill patients.    
Fluid resuscitation
Fluid resuscitation is probably the major therapy aimed at restoring circulating 
volume and consequently increasing cardiac output and arterial blood pressure in 
shock patients. Pottecher et al. showed that sublingual microcirculatory perfusion in 
severely septic and septic shock patients was significantly improved following fluid 
loading [40]. However, as the changes in microcirculation did not correlate to changes 
in macrocirculation the authors suggested that the macro- and microcirculation do 
not have the same dose-response to fluid loading. This was also observed by Ospina-
Tascon et al. investigating the response of the macro- and microcirculation to fluid 
loading in the early (within 24 hours after diagnosis) or late (more that 48 hours after 
diagnosis) phase of septic shock [41]. The authors found that the microcirculatory 
parameters did increase after fluid loading in the early phase of septic shock, but not 
in the late phase despite significant increases in cardiac output and arterial blood 
pressure. In patients undergoing major abdominal surgery, Jhanji et al. compared 
stroke volume-guided versus central venous pressure-guided fluid therapy with respect 
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to their effects on microcirculatory perfusion and renal function [42]. The main result 
was that microvascular flow remained normal in the stroke volume-guided therapy 
group, but decreased in the central venous pressure-guided therapy group. Acute 
kidney injury was also found more frequently in the central venous pressure-guided 
therapy group. Hence, these studies indicate that fluid loading is an essential first step 
in the resuscitation of the microcirculation. 
Blood transfusion 
Long before William Harvey described the theory of the circulation of blood, transfusion 
of blood had been described on several occasions. The first known transfusion was 
performed on Pope Innocent VIII in 1490. The blood of three ten years old boys (who 
died shortly after the procedure) was supplied into the veins of the sick pope [43]. The 
first documented animal-to-animal transfusion attempts were performed by Richard 
Lower and Jean-Baptiste Dennis in 1665. In 1667, Lower and Dennis each performed 
first animal-to-human transfusion with sheep and lambs as donors. The next important 
step in transfusion medicine was taken by James Blundell, an English obstetrician, 
who performed his first transfusion in 1818. Between 1818 and 1829, Blundell 
performed 10 experiments using human blood, of which only 4 had been successful. 
However, until the 20th century, blood transfusion remained a risky treatment due to 
fatal hemolytic transfusion reactions and coagulation of donor blood. The discovery of 
ABO blood groups by Karl Landsteiner in 1901 and application of sodium citrate as an 
anticoagulant solution by Richard Lewisohn in 1915 had a major impact on transfusion 
medicine. The introduction of the Rhesus blood group system by Karl Landsteiner 
and Alexander Wiener in 1940 was again a huge step forwards. Also both World Wars 
heavily stimulated transfusion medicine and opened new research areas on colloid or 
plasma resuscitation. The past three decades were mainly focused on improving the 
quality of stored blood.
At present, the studies on transfusion medicine are focused on the role of the 
quality of the transfused blood. As the ultimate aim of RBC transfusions is to promote 
microcirculatory oxygen delivery, the underlying disease should also be taken into 
consideration as this may interfere with the efficacy of transfusion. For example, in 
some disease states such as sepsis, blood transfusion has been shown to be ineffective 
in improving the microcirculation possibly due to altered rheological, coagulation, 
and inflammation factors already present in the host circulation in combination with 
microvascular obstruction and shunting often seen in septic patients [2,4]. 
Only few studies have investigated the effects of RBC transfusions on the 
microcirculation to date [7,44-47]; only three studies have shown a beneficial effect 
of RBC transfusions on the microcirculation: one in adults undergoing cardiac surgery 
[44], one in hematological outpatients [45], and one in anemic preterm infants [46]. 
The contrasting results of these studies might be explained by variations in patient 
populations as the studies showing no effect of RBC transfusions were carried out 
in (septic) intensive care patients [47], in which the microcirculation is significantly 
impaired due to endothelial dysfunction and abnormal endogenous RBCs. These 
depressed microcirculatory conditions are less prevalent in surgical patients [44], 
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hematological outpatients [45], and preterm infants [46], possibly explaining the 
discrepancy between these studies. 
Sakr et al. evaluated the sublingual microcirculation in 35 septic patients using 
orthogonal polarization spectral imaging. Measurements were performed just before 
RBC unit transfusion and one hour after transfusion of leukoreduced RBC units with a 
mean age of 24 days. Although mean arterial pressure and oxygen delivery increased 
following RBC transfusion, oxygen uptake and microcirculatory parameters did not. It 
must be noted, however, a high degree of interindividual variability was established 
with an increase in sublingual capillary perfusion in patients with depressed perfusion 
at baseline and a decrease in perfusion in patients with normal baseline perfusion 
[47]. Creteur et al. obtained similar results studying muscle oxygenation, oxygen 
consumption, and microvascular reactivity using near-infrared spectroscopy in intensive 
care patients receiving one leukoreduced RBC unit with a mean age of 18 days [48]. 
In contrast, Genzel-Boroviczény et al., in pediatric patients observed an increased 
functional capillary density in the skin 2 hours and 24 hours after transfusion of 9.3-
14.2 mL of packed RBCs per kg body weight (age of packed RBCs unknown) [46]. 
In line with the study by Genzel-Boroviczény et al., our group has demonstrated an 
increased sublingual microcirculatory density and tissue oxygenation after transfusion 
of one to three RBCs units with a mean age of 18 days in cardiac surgery patients [44] 
and an increased sublingual and muscle tissue oxygenation after transfusion of two or 
three RBCs units with a mean age of 21 days in hematological outpatients [45]. In our 
studies we have verified the hypothesis that transfused blood is effective in improving 
oxygen transport to the tissue by promoting RBC delivery to the microcirculation. We 
have also elucidated the mechanism by which this phenomenon is accomplished: i.e., 
not by increasing microcirculatory flow velocity but rather by filling empty capillaries, 
by which the oxygen diffusion distances to the tissue cells is reduced. 
conclusions
An increasing amount of evidence exists emphasizing depressed microcirculatory 
function as a key cause of morbidity and mortality in a wide array of clinical scenarios. 
It has been shown that volume replacement therapy using fluids and/or blood in 
combination with vasoactive agents to modulate microvascular perfusion is essential 
for resuscitation of critically ill patients. However, even after interventions effectively 
optimizing macrocirculatory hemodynamics, high mortality rates still persist in critically 
ill patients. Therefore, rather than limiting therapy to macrocirculatory targets alone, 
microcirculatory targets should be incorporated to potentially reduce mortality rates. 
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The studies described in this thesis have been performed at the Department of 
Translational Physiology of the Academic Medical Center of the University of 
Amsterdam in close collaboration with the Department of Intensive Care of the 
Erasmus Medical Center in Rotterdam. The main goal of the collaboration between 
both departments is to translate physiological concepts to clinical scenarios and 
to introduce novel techniques into clinical practice. To this end, the Department of 
Translational Physiology uses controlled models for simulating clinical complications 
in healthy volunteers and animals. One of the key complications occurring at the 
Intensive Care Unit is the occult onset and progression of hypovolemia. Therefore, to 
study the effects of hypovolemia on the microcirculation isolated from other potentially 
confounding factors occurring in critically ill patients, we have developed a model in 
which lower body negative pressure (LBNP) is applied in healthy volunteers to induce 
central hypovolemia. The LBNP model allows elaborate physiological studies in 
subjects in which the volume status is modulated in a highly controlled environment.  
As discussed in the Introduction, the microcirculation is considered to be a complex 
system and monitoring its status and function can provide prognostic information on 
patient outcome. This thesis focuses on optical modalities for the evaluation of the 
microcirculation in hypovolemia and anemia in subjects with a healthy microcirculation 
and investigates the physiological alterations consequent to hypovolemia and anemia. 
Volume clamp plethysmography is used to continuously and noninvasively monitor 
monitor cardiac output during LBNP. To evaluate the application of volume clamp 
plethysmography in a wide range of cardiac output values, it has been compared 
to inert gas rebreathing and respired gas analysis at rest and during exercise. The 
results have been described in Chapter I. The study also implicates a validation for the 
utilization of volume clamp plethysmography during LBNP. 
Several techniques might be sensitive enough to monitor alterations in the 
microcirculation induced by hypovolemia or anemia. First, the effect of hypovolemia on 
the pulse oximeter-derived peripheral perfusion index (PPI), which reflects peripheral 
vasomotor tone, is examined in Chapter II. Second, to explore the microcirculatory 
response to hypovolemia in more detail, two different microcirculatory techniques 
are applied in Chapter III; sidestream dark field (SDF) imaging and near-infrared 
spectroscopy (NIRS) in combination with a vascular occlusion test (VOT). SDF 
imaging enables in vivo visualization of the microcirculation, while NIRS measures 
tissue oxygen saturation. A VOT is performed to assess microvascular reactivity 
and to estimate tissue oxygen consumption. Third, since in Chapter III it has been 
shown that NIRS is a sensitive monitoring tool reflecting changes in peripheral tissue 
oxygenation during progressive hypovolemia, Chapter IV explores the roles of NIRS 
application site and probing depth on its sensitivity to hypovolemia. Finally, NIRS 
has been used in a clinical scenario in Chapter V; i.e., in chronic anemic hematology 
outpatients receiving red blood cell transfusions. Although these patients are used 
to low hemoglobin levels, they still require frequent red blood cell transfusions when 
their hemoglobin levels fall below a certain threshold. We hypothesized that anemia 
in these patients would be associated with low peripheral tissue oxygenation and 
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that this would increase after the red blood cell transfusion. This is an important 
issue because the studies addressing the efficacy of red blood cell transfusion at the 
microcirculatory level have only concerned critically ill patients and showed little or no 
effect on the microcirculation.
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noninvasive cardiac outPut monitoring 
during exercise testing: Pulse contour 
analysis comPared to an inert gas reBreathing 
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aBstract
Exercise testing is often used to assess cardiac function during physical exertion to 
obtain diagnostic information. However, this procedure is limited to measuring the 
electrical activity of the heart using electrocardiography and intermittent blood 
pressure (BP) measurements and does not involve the continuous assessment of heart 
functioning. In this study, we compared continuous beat-to-beat pulse contour analysis 
to monitor noninvasive cardiac output (CO) during exercise with inert gas rebreathing 
and respired gas analysis.
Nineteen healthy male volunteers were subjected to bicycle ergometry testing 
with increasing workloads. Cardiac output was determined noninvasively by 
continuous beat-to-beat pulse contour analysis (Nexfin) and by inert gas rebreathing, 
and estimated using the respired gas analysis method. The effects of the rebreathing 
maneuver on heart rate (HR), stroke volume (SV), and CO were evaluated.
The CO values derived from the Nexfin- and inert gas rebreathing methods were 
well correlated (r=0.88, p<0.01) and the limits of agreement were 30.3 % with a 
measurement bias of 0.4±1.8 L/min. Nexfin- and respired gas analysis-derived CO 
values correlated even better (r=0.94, p<0.01) and the limits of agreement were 21.5 
% with a measurement bias of -0.70±1.6 L/min. At rest, the rebreathing maneuver 
increased HR by 13 bpm (p<0.01), SV remained unaffected (p=0.7), while CO increased 
by 1.0 L/min (p<0.01). Rebreathing did not affect these parameters during exercise. 
We conclude that Nexfin continuous beat-to-beat pulse contour analysis is an 
appropriate method for noninvasive assessment of CO during exercise.
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introduction
Exercise testing is often used to assess cardiac function during physical exertion to 
obtain diagnostic information [1]. However, this procedure is limited to measuring 
electrical activity of the heart with electrocardiography, recordings of heart rate (HR), 
and intermittent blood pressure (BP) measurements. The method does not involve 
continuous assessment of mechanical heart function even though changes in stroke 
volume (SV) and cardiac output (CO) could provide valuable clinical information. 
Clinically, CO can be measured invasively with discontinuous methods such as 
the direct Fick method and thermodilution, which are considered the gold standards 
[2-4]. These invasive methods can be cumbersome to perform and have the potential 
for adverse events. Several noninvasive methods for assessment of CO have been 
developed, such as ultrasound techniques, impedance cardiography, inert gas 
rebreathing, and pulse contour analysis. However, ultrasound techniques and 
impedance cardiography are not ideal for use during exercise. Inert gas rebreathing, 
on the other hand, is only considered suitable for discontinuous measurements.
As stated by De Waal et al. [5], “The ideal CO monitor should be reliable, 
continuous, noninvasive, operator-independent, cost-effective, and should have a 
fast response time (beat-to-beat).” Pulse contour analysis-derived CO assessment 
is considered to meet these requirements and has been incorporated into clinically 
applicable devices (e.g., Portapres and Finapres). However, the reliability of this 
method for monitoring CO has been questioned. The Finapres and its portable variant 
Portapres, which both employ Modelflow to derive CO measurements, were shown to 
be inaccurate in healthy subjects [6] and critical care patients [7], respectively. During 
moderate exercise, the Portapres Modelflow was shown to weakly correlate to CO2 gas 
rebreathing [8]. Tam et al. compared Modelflow to rebreathing [9] and Azabji Kenfack 
et al. compared Modelflow to invasively-measured intra-arterial pulse pressure profiles 
[10] and both stated that a correction factor is required for CO values derived from 
the device. Bogert et al. recently evaluated a new pulse contour analysis method, the 
Nexfin CO-trek, designed specifically for the noninvasive assessment of finger arterial 
pressure [11]. 
The Nexfin method has been validated compared to the thermodilution method 
[11] incorporating values from ~3 L/min to ~9 L/min. Consequently, whether this 
method is capable of adequate assessment of CO during exercise, where CO rises 
to higher levels, remains to be established and we therefore aimed to evaluate the 
use of the Nexfin system for continuous noninvasive CO monitoring during exercise 
and an inert gas rebreathing method. Furthermore, Nexfin-derived CO values were 
compared to CO values estimated from whole body oxygen consumption determined 
by respired gas analysis, as described by Stringer et al. [12].
methods
A group of 19 healthy males (mean±SD age 27±5 years, height 183±6 cm, and weight 
84±10 kg) was recruited for exercise testing. All participants completed a medical 
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history questionnaire and signed a written informed consent. The subjects refrained 
from intake of vasoactive medication and substances (including coffee) and intensive 
exercise from one day prior to the experiments. The study protocols were approved 
by the Medical Ethical Committee of the Academic Medical Center of the University 
of Amsterdam. 
nexfin blood pressure measurement
The Nexfin monitoring system (BMEYE B.V., Amsterdam, The Netherlands) is based on 
its predecessor, Finapres (Netherlands Organization for Applied Scientific Research, 
Biomedical Instrumentation (BMI-TNO)). The Finapres methodology uses the volume-
clamp technique of Penáz [13] and the Physiocal calibration of Wesseling et al. [14]. 
Arterial volume is clamped by applying variable pressures in an inflatable cuff around 
the finger, which counters the pulsatile arterial pressure. An optical plethysmograph 
in the cuff measures arterial volume continuously. The automatic calibration system in 
the Nexfin determines the volume at which the artery is unloaded, i.e. when transmural 
pressure equals zero, assuming that the arterial wall does not interfere with the 
measurement. Because finger arterial pressure is different from brachial pressure in 
wave shape and absolute levels, waveform transformation and level corrections are 
applied in the Nexfin system to reconstruct brachial pressure [15]. The brachial pressure 
is subsequently used to determine the pulse contour derived beat-to-beat CO. 
nexfin cardiac output
Bogert et al. described the pulse contour analysis method developed for noninvasive 
measurement of finger arterial pressure that was incorporated into the Nexfin system 
[11]. The Nexfin CO-trek pulse contour method uses the pulsatile systolic area of the 
blood pressure curve above the diastolic pressure and between aortic valve opening 
and closing, as determined by upstroke and incisura. This time integral provides SV after 
division by arterial vascular impedance. A three element Windkessel model, based on 
gender, age, height, and weight of the subjects, is used to obtain impedance. Arterial 
impedance varies nonlinearly with pressure, which is important for the calculation of 
SV from the pulsatile systolic area of the blood pressure curve in the presence of 
changes in pressure and inherent changes in aortic stiffness and thus arterial vascular 
impedance. Each pulsatile systolic area provides SV. The CO is calculated as the 
product of SV and HR, which is determined from the interbeat interval. 
innocor inert gas rebreathing
The rebreathing device (Innocor, Innovision A/S, Odense, Denmark) measures 
gas concentrations in a gas mixture of enriched concentrations of oxygen (O2) and 
soluble (N2O) and insoluble (NF6) gases from a closed rebreathing assembly [16]. 
During the rebreathing procedure, blood-soluble N2O diffuses from the alveoli to 
the systemic circulation, and blood-insoluble NF6 remains in the pulmonary fields. 
The disappearance rate in the bag volume is proportional to the pulmonary blood 
flow, which is assumed to be equal to the CO of the left ventricle [17]. Changes in 
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the composition of the mixture are measured and analyzed with a photoacoustic 
sensor, and the last five breaths are used by the Innocor device to calculate CO. This 
assumption is considered valid particularly during exercise when the pulmonary blood 
flow increases and pulmonary volume expands. The accuracy and precision of the inert 
gas rebreathing technique has been established by comparisons to the thermodilution 
and the Fick methods [16,18-20]. 
nexfin vs. inert gas rebreathing 
All of the subjects were provided with careful instructions and familiarized with the 
rebreathing test before the start of the protocol. Subjects were seated on a bicycle 
ergometer, and BP and HR were measured automatically with a sphygmomanometer 
placed around the left upper arm. The Nexfin finger cuff was applied on the middle 
phalanx of the middle finger of the right hand, which was kept at heart level using a sling 
to prevent the potential influence of pressure or movement artifacts during exercise. 
After the Nexfin signal was stabilized (defined as at least two minutes of adequate BP 
traces without oscillations), the baseline rebreathing test was performed according to 
the instructions of the manufacturer. After baseline measurements were successfully 
collected, the participants started to cycle with an increasing workload of 25 Watts/
min until their HR reached 150 bpm. Another rebreathing test was subsequently 
performed. The rebreathing procedure consisted of five to seven breaths at a breath 
rate of 20/min and the last five breaths (i.e., 15 seconds) were used for derivation 
of CO. Nexfin provided beat-to-beat values for CO, which were averaged over the 
same period as the last five breaths of the rebreathing procedure (i.e., 15 seconds, 
regardless of the HR).  
nexfin vs. repired gas analysis 
A subset of the original subject population (n=9) participated in an additional exercise 
protocol similar to the protocol used to compare the Nexfin- and Innorcor-derived CO 
measurements. In this study, the exercise rate was increased until exhaustion. During 
this protocol, volume was measured with a bi-directional digital volume transducer 
(DVT; dead space 30 mL), which was attached to a face mask (Hans Rudolph Inc, 
Kansas City, MO; dead space 40 mL). Oxygen uptake (VO2) and carbon dioxide 
production (CO2) were measured using the Oxycon Pro (Viasys Healthcare, Hoechberg, 
Germany). VO2 and CO2 were averaged over 30 seconds. VO2max was defined as the 
average VO2 in the last 30 seconds of the experiment (i.e., at exhaustion), and the 
%VO2max was calculated as VO2/VO2max ∙ 100. According to Stringer et al. [12], CO 
can be estimated from VO2 and %VO2max using the following equation: estimated 
CO=0.1∙VO2/(5.721+(0.1047∙%VO2max)). Figure 3 shows the Nexfin- and respired gas 
analysis-derived cardiac output measured at different workloads.
data analysis
Nexfin-derived CO values were compared to inert gas rebreathing- and respired gas 
analysis-derived CO values using Spearman correlation and linear regression analysis. 
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Agreement between the techniques was assessed using Bland-Altman analysis [21] 
and Critchley and Critchley analysis [22]. Bland-Altman analysis generates a plot of the 
difference between the CO values measured with two techniques versus the average 
value measured by the techniques and provides a measurement bias expressed as the 
mean±SD [21]. The Critchley and Critchley analysis calculates the limits of agreement 
by dividing 2xSD of the CO measurement bias by the overall measured average CO. 
Critchley and Critchley have proposed that the limits of agreement should be ≤30 % 
to represent proper agreement between two techniques [22], while Peyton and Chong 
accept a cut-off value of 45 % [23].
To determine the effects of the rebreathing test on hemodynamic parameters, 
Nexfin-derived HR, SV, and CO were measured and averaged for 15 seconds before 
the rebreathing test and for 15 seconds during the test. The data are expressed as 
mean±SD. The statistical significance of the difference in values obtained before and 
during the rebreathing test was determined using the Wilcoxon signed rank test. 
Values of p<0.05 were considered statistically significant.
results
nexfin vs. inert gas rebreathing
Figure 1A depicts the Nexfin- versus inert gas rebreathing-derived CO values, which 
were highly correlated (Spearman r=0.88, p<0.01). In Figure 1B, a Bland-Altman 
plot shows a measurement bias of 0.43±1.8 L/min between the Nexfin and inert gas 
rebreathing. The mean±SD CO of the data set (i.e., rest and exercise, and Nexfin 
and inert gas rebreathing measurements) was 11.9±4.6 L/min. The overall limits of 
agreement were (2x1.8/11.9) 30.3 %. The limits of agreement at rest were somewhat 
higher (34 %) than during exercise (26 %).
Figure 1. Panel A shows the values of Nexfin- versus inert gas rebreathing-derived cardiac 
output (CO). Panel B shows a Bland-Altman plot depicting the difference between the CO values 
measured by the two techniques (i.e., Nexfin-derived CO values minus inert gas rebreathing-
derived CO values) versus the average value measured by the techniques.
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nexfin vs. respired gas analysis
Figure 2A depicts the Nexfin- versus respired gas analysis-derived CO values, which 
were highly correlated (Spearman r=0.94, p<0.01). In Figure 2B, a Bland-Altman 
plot shows a measurement bias of -0.70±1.6 L/min between Nexfin and respired 
gas analysis. The mean±SD CO of the data set (i.e., Nexfin and respired gas analysis 
measurements) was 14.9±4.5 L/min. The overall limits of agreement were (2x1.6/14.9) 
21.5 %. Figure 3 shows the Nexfin- and respired gas analysis-derived cardiac output 
measured at different workloads.
Figure 2. Panel A shows the values of Nexfin- versus respired gas analysis-derived cardiac 
output (CO). Panel B shows a Bland-Altman plot depicting the difference between the CO values 
measured by the two techniques (i.e., Nexfin-derived CO values minus respired gas analysis-
derived CO values) versus the average value measured by the techniques.
Figure 3. Nexfin- and respired gas analysis-derived cardiac output measured at different 
workloads. A two-way analysis of variance showed that p>0.05 at all work load levels, indicating 
no significant differences between Nexfin and respired gas analysis-derived measurements.
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discussion
The aim of this study was to compare the use of the Nexfin system for continuous 
noninvasive CO monitoring during exercise compared with inert gas rebreathing and 
respired gas analysis. Nexfin- and inert gas rebreathing-derived CO values were well 
correlated and the limits of agreement marginally meet the Critchley and Critchley 
criterion (i.e., 30.3 % versus the threshold of ≤30 %). Nexfin- and respired gas analysis-
derived CO values were better correlated, and the limits of agreement easily met 
the Critchley and Critchley criterion (i.e., 21.5 %). We demonstrated that the 
Table 1. The values of Nexfin-derived heart rate, stroke volume, and cardiac output during rest and 
exercise and before and during the Innocor inert gas rebreathing test.
rest exercise
Before 
rebreathing
during 
rebreathing
p-value Before 
rebreathing
during 
rebreathing
p-value
Heart rate bpm 83±11 96±13 < 0.01 150±6 151±5 0.30
Stroke 
volume mL 80±9 80±13  0.73 106±13 107±14 0.89
Cardiac 
output L/min 6.6±1.3 7.6±1.5 < 0.01 15.9±1.9 16.1±2.0 0.61
Table 2. The cardio-respiratory performance of a cohort of 9 subjects performing an exercise test 
with increasing work load for comparison of respired gas analysis-derived and Nexfin-derived cardiac 
output values.
mean±sd
Maximum work rate 286±40 W
Maximum oxygen uptake 3.2±0.5 L/min
Maximum breathing frequency 39±3/min
Maximum heart rate 182±9 bpm
Maximum cardiac output 20.0±3 L/min
Maximum respiratory exchange ratio 1.3±0.1
Maximum VO2/kg 41±6 mL/min/kg
Maximum oxygen pulse 19±4 mL/bpm
effects of the inert gas rebreathing method on hr, sv, and co
In table 1, the Nexfin-derived HR, SV, and CO measurements before and during the 
Innocor rebreathing test shows the effects of the rebreathing test on HR, SV, and CO at 
rest and during exercise. At rest, the CO increased from 6.6±1.3 before the rebreathing 
test to 7.6±1.5 L/min (p<0.01) during the test. This is the result of an increase in HR 
from 83±11 to 96±13 bpm (p<0.01). SV did not change significantly during rebreathing 
(p=0.73). The rebreathing test did not affect CO, HR, or SV during exercise.
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rebreathing method significantly increased HR and CO and that CO measurements at 
complete rest are therefore not possible using this method. 
Previous studies on the application of pulse contour analysis for CO assessment 
during exercise have suggested that a calibration factor is needed [9,10]. In contrast, 
Sugawara et al. described good correlation between Portapres Modelflow and 
Doppler echocardiography during exercise [24]. We found that Nexfin-derived CO 
values correlated well with inert gas rebreathing- and respired gas analysis-derived CO 
values with an acceptable measurement bias of ≤0.7 L/min.  The limits of agreement 
for Nexfin and inert gas rebreathing were higher at rest (34 %) than during exercise 
(26 %). Hence, the limits of agreement met the Critchley and Critchley criterion during 
exercise, but not at rest. The proposed 45 % benchmark from Peyton and Chong [23] 
was easily met during both rest and exercise. The limits of agreement for Nexfin and 
respired gas analysis [12] were far below the Critchley and Critchley criterion (i.e., 
21.5 %). Collectively, these results show that Nexfin can be used to measure CO over 
a large range of CO values (table 2). 
The Nexfin determinations of CO were an average of ~0.5 L/min higher than the 
Innocor measurements, especially at rest. It has been suggested that rebreathing tests 
are more accurate when there is a high CO compared to a low CO and that the accuracy 
of this method could be improved as a result of exercise [25]. The physiological 
explanation regarding the improved accuracy of the rebreathing method during 
exercise could be that increased pulmonary volume and blood flow and decreased 
shunting leads to an improved mixing of gases because incomplete mixing has been 
shown to result in an underestimation of CO [18,19]. However, a study by Jarvis et al. 
showed an underestimation of CO by rebreathing during exercise and suggested that 
an increased velocity of blood flow during exercise shortens the recirculation time of 
the rebreathing gas mixture [26]. This discrepancy might be due to the use of different 
rebreathing gases (C2H2 instead of N2O and NF6) or variations in protocols. Because 
there are a variety of devices and gas mixture compositions used in the rebreathing 
method, the results from different studies should be compared with caution. 
In this study, we chose an inert gas rebreathing method for evaluation of the Nexfin 
method for assessment of CO because this technique measures CO noninvasively. 
However, rebreathing is a discontinuous method that may constitute an extra load 
to perform during exercise, especially for patients with heart failure, and has been 
shown to significantly increase HR and CO [17,27]. This we have also shown here. 
Hence, although this technique enables the noninvasive quantitative assessment of 
CO during exercise, it might not be the method of choice in every clinical scenario. 
In contrast, pulse contour analysis provides a reliable, continuous, noninvasive, 
operator-independent, and beat-to-beat responsive method for assessment of CO in 
healthy subjects and patients who have undergone cardiac surgery [11]. In addition 
to inert gas rebreathing, we compared the Nexfin-derived CO values to estimated 
CO values derived from respired gas analysis. The respired gas analysis method has 
been introduced by Stringer et al. and was compared to the direct Fick method [12]. 
The authors demonstrated that CO can be accurately estimated from VO2 and VO2max 
during exercise in normal subjects and patients with heart failure.   
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We acknowledge several shortcomings in this study. First, we did not include one of 
the gold standard methods for CO assessment in our protocol, such as thermodilution 
or the Fick method. However, the Nexfin, the inert gas rebreathing method, and 
the respired gas analysis method have all been compared to these gold standards 
[11,12,25] and applying thermodilution or the Fick method during exercise could 
introduce adverse events due to the invasive nature of these techniques. In addition, 
the rebreathing test, the Fick method, and the thermodilution method all calculate an 
average CO over a certain period of time, assuming a steady state condition. However, 
even successive repetition of the thermodilution method under stable hemodynamic 
conditions result in alterations of CO by >1.0 L/min [28], indicating that CO can vary 
substantially during a short period of time. The safety and validity of thermodilution 
were questioned in a study by Williams et al. [29]. In addition, agreement between 
the Fick method and the thermodilution method remains a debate [30,31]. Other 
noninvasive methods for continuous CO assessment, such as ultrasound techniques 
and impedance cardiography, are not ideal for use during exercise. Second, 
rebreathing measurements were performed at a fixed breathing rate of 20/min both 
at rest and during exercise. Because the Nexfin provides beat-to-beat measurements 
of CO, there were more Nexfin measurements averaged over the rebreathing interval 
(i.e., 15 s, regardless of HR) during exercise compared to the measurements at rest. 
Third, although we compared the continuous Nexfin measurements of CO to the 
discontinuous inert gas rebreathing measurements, we did not perform repeated 
rebreathing measurements as suggested by Peyton et al. [20], because rebreathing 
tests can be quite exhausting and require a specific breathing rate and volume for 
accurate measurements. Overall, we found that Nexfin- and inert gas rebreathing-
derived CO measurements were well correlated over a large range of CO values and, 
using the Nexfin system, we demonstrated that the rebreathing method significantly 
affected HR and CO at rest.
conclusions
Nexfin continuous beat-to-beat pulse contour analysis is an appropriate method for 
noninvasive CO assessment during exercise and the rebreathing method significantly 
affected HR and CO at rest. 
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aBstract 
To investigate the ability of the Peripheral Perfusion Index (PPI) to reflect early peripheral 
vasoconstriction during progressive hypovolemia, we applied lower body negative 
pressure (LBNP) in twenty-five healthy male volunteers until onset of cardiovascular 
collapse. and we compared the ability of volume clamp plethysmography and PPI to 
induced central hypvolemia.
Twenty-five healthy volunteers were subjected to a stepwise LBNP protocol from 
0 to -20, -40, and -60 mmHg (5 min per step). Throughout the procedure, stroke 
volume (SV), heart rate (HR), blood pressure (BP), systemic vascular resistance (SVR), 
and cardiac output (CO) were recorded using volume clamp finger plethysmography 
(Nexfin). Assessment of the PPI was done by pulse oximetry (Masimo SET). 
During the first LBNP step (-20 mmHg), SV decreased (10 %, p<0.001), while 
HR remained unaltered. In contrast, SVR increased (10 %, p<0.001). PPI decreased 
significantly with 47 % (p<0.001). During further progression of LBNP, SV decreased 
and HR increased proportionally to the applied negative pressure. SVR and PPI 
remained around the LBNP=-20 mmHg level throughout the rest of the protocol. As 
a result of adequately functioning compensatory mechanisms, BP and CO did not 
change significantly throughout the experiment.
We conclude that LBNP results in a decrease in SV and an increase in HR and SVR. 
The latter two can be successfully monitored using the applied pulse oximeter. PPI 
can be used as a complementary hemodynamic monitoring technique for the early 
detection of central hypovolemia. 
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introduction
Disturbance of the peripheral perfusion can be an early predictor of tissue 
hypoperfusion and as such a warning signal of ongoing circulatory shock in critically 
ill patients [1-2]. Till date, detection of hypovolemia in the early phase remains of 
prime importance, but is complicated to monitor due to physiological compensatory 
responses , such as increased heart rate (HR) and systemic vascular resistance (SVR), 
induced by hypovolemia. Vasoconstriction in the peripheral tissues redistributes the 
blood flow to more central compartments [3-5] and limits the usefulness of mean 
arterial pressure (MAP) and cardiac output (CO) as indicators for mild hypovolemia 
during early stage of shock [6].  When conventional hypovolemic signs occur, 
circulating blood volume is already ≥30 per cent diminished. At this point, most of 
the CO is used to maintain perfusion of vital organs, resulting in abnormal tissue 
perfusion of peripheral tissues and, eventually, hypovolemic shock [7]. Therefore it 
is important to recognize hemodynamic instability before this point. Monitoring of 
the early compensatory peripheral mechanisms might better indicate the onset of 
hypovolemic or low flow shock in the acute stage of the disease [4].
The peripheral perfusion index (PPI), derived from the photo-electric plethysmographic 
signal of the pulse oximeter, has been established as a very useful noninvasive method 
for the assessment of peripheral vasomotor tone in healthy volunteers and critically ill 
patients [2,8].  Because a pulse oximeter is universally available in the operating room, 
emergency room, and intensive care unit, it could potentially be used for the detection 
of peripheral hypoperfusion in the early response to ongoing hypovolemia in these 
settings. However, the sensitivity of this modality to mild changes in volume status has 
never been investigated in a controlled model of hypovolemia.
In the present study we therefore aimed to test the hypothesis that the PPI would 
decrease (reflecting peripheral vasoconstriction) early in the response to progressive 
hypovolemia. To this end, we employed a model of controlled central hypovolemia 
in healthy volunteers: lower body negative pressure (LBNP). During application 
of LBNP, the circulating volume is redistributed from the upper to the lower body 
creating central hypovolemia [9], which allows studying the cardiovascular responses 
to hypovolemia under controlled conditions.
methods
subjects
This study was conducted in a research laboratory at a university affiliated teaching 
hospital. We recruited twenty-five healthy volunteers with no history of cardiac events 
nor receiving any vasoactive medication. All participants completed a medical history 
and underwent an exercise electrocardiogram. To minimize potential confounding 
factors [10], we recruited a homogenous group of male volunteers in terms of physical 
fitness and age. The volunteers were instructed not to consume caffeine-containing 
drinks or practice intensive exercise ≤12 hours prior to the experiments. The study 
protocol was approved by the Medical Ethics Committee of the Academic Medical 
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Center of the University of Amsterdam, and written informed consent was obtained 
from all subjects. 
measurements
Subjects were placed with their lower body in an air-tight chamber with a seal applied 
at the level of the iliac crests. The negative pressure within the chamber could be 
manually adjusted using a variable vacuum source. Baseline recordings were made 
after a 10-min stabilization period prior to LBNP application. Then, LBNP was applied 
progressively at a 5 minute stepwise fashion from 0 to -20, -40, and -60 mmHg. 
The LBNP protocol could be immediately terminated when the subject developed 
presyncope, which was defined as a drop in systolic blood pressure of >15 mmHg 
from baseline, or experienced symptoms of impending syncope such as dizziness, 
light-headedness, nausea, or visual disturbances [11]. 
hemodynamic parameters 
Hemodynamic parameters, including MAP, CO, stroke volume (SV), HR, and 
SVR, were continuously and non-invasively measured using volume clamp finger 
plethysmography (Nexfin, BMEYE, Amsterdam, The Netherlands) with the cuff placed 
around the left index finger. The Nexfin device is extensively described elsewhere 
and has shown to provide reliable measurements of these hemodynamic parameters 
[12-13]. In brief, this method applies variable pressure in an inflatable cuff around the 
finger, countering the pulsatile arterial pressure. An optical plethysmograph placed 
in this cuff measures arterial volume and a calibration system determines the volume 
at which the artery is unloaded (i.e. when transmural pressure equals zero and no 
interference of the arterial wall occurs). Since brachial and finger arterial pressure are 
physiologically different, waveform transformation and correction are applied in order 
to reconstruct brachial arterial pressure. The study of Bogert et al. demonstrated that 
Nexfin-derived CO correlated well to thermodilution-derived CO. Systemic vascular 
resistance is calculated as SVR = ([MAP – central venous pressure] • 80/CO). In the 
Nexfin device, central venous pressure is set at 5 mmHg, which might lead to minor 
inaccuracies, especially at very low MAP. However, as we only monitored hemodynamic 
under compensated conditions, MAP remained sufficiently high and SVR could be 
estimated reliably [14]. 
Peripheral Perfusion index (PPi)
The PPI (Masimo SET® pulse oximetry Perfusion Index, Radical 7, Basingstoke, 
Hants, UK) provides a noninvasive parameter reflecting changes in peripheral 
vasomotor tone [15-16]. It is derived from the photo-electric plethysmographic signal 
of the pulse oximeter and has been used as a noninvasive measurement of peripheral 
perfusion in healthy volunteers and critically ill patients [2,8]. The technique is based 
on two light sources that emit light at wavelengths of 660 and 940 nm through the 
cutaneous vascular bed of the distal side of the index finger. As other tissues, such 
as connective tissue, bone, and venous blood, also absorb light, the pulse oximeter 
distinguishes the pulsatile component of arterial blood from the nonpulsatile 
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component of venous and capillary blood, and other tissues. Using a two-wavelength 
system the pulsatile component is used to calculate the arterial oxygen saturation. The 
PPI is calculated as the ratio between the pulsatile component (arterial compartment) 
and the nonpulsatile component (venous and capillary blood, and other tissues) of 
the light reaching the detector of the pulse oximeter.  This ratio is independent of 
the hemoglobin oxygen saturation. Because a change in peripheral vasomotor tone 
primarily causes a proportional change in the pulsatile component of the signal, the 
PPI changes accordingly. As a result, the PPI value reflects changes in peripheral 
vasomotor tone. 
statistics
Unless otherwise specified, results are presented as median [25 % - 75 %]. Comparative 
analysis of data sets was performed using (nonparametric) repeated measurements 
one-way analysis of variance tests. Data were plotted and analyzed using GraphPad 
Prism software (GraphPad Prism Software, San Diego, CA). P<0.05 was regarded 
statistically significant.
results
Of the 25 male subjects (mean ± SD age 23 ± 6 yrs; weight 82 ± 2 kg; and height 
182 ± 1 cm), 25 completed the LBNP=-20 and -40 mmHg steps and 24 completed the 
LBNP=-60 mmHg step. 
Global hemodynamic parameters and PPI are presented in Table 1 and 
Figure 1A. At onset of mild central hypovolemia (i.e., from baseline to LBNP=-20 
mmHg), SV decreased from 113 [107-126] mL to 101 [95-112] mL (i.e., -11 %), HR 
remained unaltered (59 [53-69] bpm to 62 [59-68] bpm (p>0.05), while SVR significantly 
increased from 1023 [972-1140] to 1141 [1057-1267] AU (+12 %; p<0.001). Progressive 
mild hypovolemia (i.e. LBNP≤-40 mmHg) resulted in a progressive decrease of SV 
(≤20 % of baseline; p<0.001) and increase of HR (≥ +17 %; p<0.001). SVR remained 
elevated around the same level. MAP and CO were maintained around baseline levels 
throughout the experiment. 
Table 1. Descriptive analysis (median [25 % -75 %]) of heart rate (HR), stroke volume (SV), cardiac 
output (CO), mean arterial pressure (MAP), systemic vascular resistance (SVR), and peripheral perfusion 
index (PPI) during progressive application of lower body negative pressure (LBNP) from 0 mmHg to -60 
mmHg. ‡ p<0.001 vs. LBNP = 0 mmHg, * p<0.001 vs. previous time point.
lBnP level 0 mmhg -20 mmhg -40 mmhg -60 mmhg
HR (bpm) 59 [53-69] 62 [59-68] 69‡* [66-81] 84‡* [78-95]
SV (mL) 113 [107-126] 101‡* [95-112] 89‡* [83-98] 74‡* [66-83]
CO (L/min) 6.7 [6.2-7.6] 6.2 [5.9-7.1] 6.0 [5.8-7.0] 6.0 [5.7-6.9]
MAP 91 [84-97] 92 [88-99] 91 [85-95] 87 [83-94]
SVR (AU) 1023 [972-1140] 1141‡* 1057-1267] 1152‡ [1035-1267] 1120‡ [1016-1278]
PPI (%) 2.3 [1.6-3.6] 1.2‡* [0.8-1.8] 1.2‡ [0.9-1.9] 1.3‡ [0.9-1.7]
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Similar to SVR, PPI immediately decreased at the onset of LBNP from 2.3 [1.6-3.6] 
% to 1.2 [0.8-1.8] % (p<0.001) at LBNP=-20 mmHg and remained around this level 
during the rest of the protocol. Comparing relative changes, PPI demonstrated to 
be highly sensitive with a 47 % decrease at LBNP=-20 mmHg compared to the 11 
% decrease in SV, the 5 % increase in HR, and the 12 % increase in SVR (Figure 1A). 
Changes in PPI showed no significant differences after the first decrease at LBNP=-20 
mmHg. Interestingly, this pattern is similar to the SVR, albeit that the magnitude of 
change was significantly larger for the PPI. 
Figure 1. Stroke volume (SV), heart rate (HR), systemic vascular resistance (SVR), and peripheral 
perfusion index (PPI) plotted as percentage of baseline during progressive application of lower body 
negative pressure (LBNP) from 0 mmHg to -60 mmHg (A) and the same parameters in the person with 
impending cardiovascular collapse at LBNP=-40 mmHg (B). 
One subject did not complete the study due to impending cardiovascular collapse. 
Because this persons’ response to increasing negative pressure was markedly different 
from the other participants, we show the time course of the relative changes in SV, 
HR, SVR, and PPI in Figure 1B. In the non-collapsing subjects at LBNP=-40 mmHg, the 
median SV was 89 mL, HR was 69 bpm, SVR was 1152 AU, and PPI was 1.2 %, while in 
the collapsing subject the SV was 86 mL, HR was 83 bpm, SVR was 1014 AU, and PPI 
was 0.5 %. Hence, especially HR and PPI differed markedly between the collapsing 
subject and the non-collapsing subjects. This combination of very high HR and very 
low PPI at LBNP=-40 mmHg was only found in the subject that collapsed.
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discussion
The aim of the present study was test the hypothesis that progressive central 
hypovolemia created by application of LBNP would result in a decreased PPI, reflecting 
peripheral vasoconstriction in response to hypovolemia. We found that PPI was highly 
sensitive to mild hypovolemia at LBNP=-20 mmHg with a 47 % decrease compared 
to the 11 % decrease in SV, the (non-significant) 5 % increase in HR, and the 12 % 
increase in SVR, but was unresponsive during further reduction of the central circulating 
volume at higher levels of LBNP. Furthermore, we have shown that, in contrast to 
the SVR and PPI, HR was unresponsive to the first step of LBNP, but did increase 
progressively at higher levels of LBNP. During the entire protocol, CO and MAP were 
maintained around baseline levels which indicated adequate compensation of the 
reduced central hypovolemia. As such we have demonstrated a biphasic response 
to progressive hypovolemia in which first the peripheral perfusion is decreased (as 
reflected by increased SVR and decreased PPI) and subsequently the HR is increased. 
This illustrates that PPI might be a valuable parameter for detecting the onset of 
hypovolemia and, under conditions of significantly reduced PPI, HR might be used to 
monitor further progression of hypovolemia (although HR might be affected by other 
factors also associated with critical illness). Both parameters can be obtained from a 
single pulse oximeter. 
The early detection of hypovolemia is of key importance in the management of 
critically ill patients. However, physiological compensatory factors, such as increased 
HR and SVR, limit the use MAP and CO as indicators for hypovolemia [6]. When CO 
and MAP start to fall, circulating blood volume is already ≥30 % reduced [7]. Therefore, 
recognizing hemodynamic instability before this point is key in the prevention of 
hypotension and hypoperfusion-induced (multiple) organ failure in these patients. 
To this end, monitoring the early compensatory peripheral mechanisms might 
provide better parameters indicating the onset of hypovolemia [4]. As shown here 
and in previous studies, the pulse oximeter-derived PPI might be a very useful and 
noninvasive method for the detection in changes in peripheral vasomotor tone in 
response to volume status alterations [2,8]. 
A possible explanation for the rapid response of PPI at onset of hypovolemia 
and its non-responsive behavior during further progression of hypovolemia could be 
that of limited vasoconstrictor reserve [17]. The concept of vasoconstrictor reserve is 
paralleling the chronotropic reserve, i.e. the major determinant of residual CO capacity. 
During normal conditions, a rise in HR and a functional sympathetic response during 
orthostatic stress is aimed at maintaining CO within normal physiological limits [18]. 
However, the degree of sympathetic reserve available for vasoconstriction is finite and 
may vary among subjects/patients, it might be one of the determinants underlying the 
individual variability in orthostatic tolerance [19]. 
Previous studies [20-21] suggest that lack of vagal tone results in reduced or 
total loss of vasoconstriction and occur at the onset of cardiovascular collapse. 
Hemodynamic instability leading to this collapse has been associated with reduced 
acute sympathetic baroreflex response [22-23] and abrupt sympathetic neural 
withdrawal [21]. Cardiovascular collapse becomes imminent when cardiac chronotropic 
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and peripheral vasoconstrictive mechanisms can no longer adequately compensate 
for progressive hypovolemia. This is supported by previous studies demonstrating 
the phenomenon of paradoxical vasodilation in patients with depressed baroreceptor 
unloading [24] and congestive heart failure [25] during mild central hypovolemia (i.e. 
LBNP = -20 mmHg) induced by LBNP. 
The PPI has been shown to be an early indicator of acute changes in peripheral 
vasomotor tone in response to changes in central blood volume. The inclusion of 
PPI in pulse oximetry is a recent advance in clinical monitoring and makes it easy 
applicable at the bedside. This noninvasively assessed PPI has been found to correlate 
with hypoperfusion in critically ill patients and can be used to predict the severity of 
illness [1,2,15,26]. We therefore suggest that, in combination with HR, PPI can be 
used as a complementary hemodynamic monitoring technique for the early detection 
of hemodynamic instability in trauma and intensive care patients. It should be noted 
though, that PPI remains unresponsive during further progression of hypovolemia and 
cannot differentiate between progressive hypovolemia and mild hypovolemia, which 
might be of vital importance for follow up and resuscitation. 
This study has some limitations that should be acknowledged. First, although 
volume redistributions with LBNP are similar to those that occur during hemorrhage, we 
did not induce severe hypovolemia or hypovolemic shock. Instead, we were interested 
in the ability of the PPI to detect early peripheral vasoconstrictor responses in the 
compensated phase of hypovolemia. This, we clearly showed, as changes in PPI indeed 
occurred immediately at onset of the LBNP-induced volume shift. Second, we did not 
determine systemic hemodynamic parameters using invasive methods such as arterial 
or venous catheters, but we have used the noninvasive Nexfin system. This system, 
as well as its predecessors, have been extensively validated and have been shown to 
provide reliable measurements of cardiovascular parameters [12]. Third, because the 
PPI is derived from the plethysmographic signal, it has been questioned whether, in 
case of peripheral vasoconstriction, the pulse waveform is sufficient to register acute 
hemodynamic perfusion changes [27]. However, we found no indications during our 
protocol that the detected pulse waveform was of insufficient amplitude. Furthermore, 
it has previously been shown that PPI is a reliable technique for monitoring peripheral 
perfusion during systemic hemodynamic changes in critically ill patients [2,8] and 
during major surgery [28]. 
conclusions
The pulse oximeter-derived PPI is a sensitive indicator for the early detection of 
hemodynamic compensation in response to LBNP-induced central hypovolemia. As 
such, PPI can be used as a complementary hemodynamic monitoring technique for 
the early recognition of hemodynamic instability in intensive care patients.
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aBstract
The objective of the present study was to test the hypothesis that controlled, 
adequately compensated, central hypovolemia in subjects with intact autoregulation 
would be associated with decreased peripheral microcirculatory diffusion and 
convection properties and, consequently, decreased tissue oxygen carrying capacity 
and tissue oxygenation. Furthermore, we evaluated the impact of hypovolemia-
induced microcirculatory alterations on resting tissue oxygen consumption. To this 
end, 24 subjects were subjected to a progressive lower body negative pressure (LBNP) 
protocol of which 14 reached the end of the protocol. At baseline and at LBNP=-60 
mmHg, sidestream dark field (SDF) images of the sublingual microcirculation were 
acquired to measure microvascular density and perfusion; thenar and forearm tissue 
hemoglobin content (THI) and tissue oxygenation (StO2) were recorded using near-
infrared spectroscopy (NIRS); and a vascular occlusion test (VOT) was performed to 
assess resting tissue oxygen consumption rate. SDF images were analyzed for total 
vessel density (TVD), perfused vessel density (PVD), the microvascular flow index 
(MFI), and flow heterogeneity (MFIhetero). We found that application of LBNP resulted 
in: 1) a significantly decreased microvascular density (PVD) and perfusion (MFI and 
MFIhetero); 2) a significantly decreased THI and StO2; and 3) an unaltered resting 
tissue oxygen consumption rate. In conclusion, using SDF imaging in combination 
with NIRS we showed that controlled, adequately compensated, central hypovolemia 
in subjects with intact autoregulation is associated with decreased microcirculatory 
diffusion (PVD) and convection (MFI and MFIhetero) properties and, consequently, 
decreased tissue oxygen carrying capacity (THI) and tissue oxygenation (StO2). 
Furthermore, using a VOT we found that resting tissue oxygen consumption was 
maintained under conditions of adequately compensated central hypovolemia.
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introduction
Hypovolemia is a common clinical complication occurring in operating rooms, 
emergency rooms, and intensive care units [1-3]. The hypovolemia-associated reduction 
in stroke volume (SV) is physiologically countered by compensatory mechanisms 
such as increased heart rate (HR) and peripheral (micro)vascular tone to prevent the 
consequent decrease in blood pressure and organ perfusion [4-6]. The peripheral 
microcirculation therefore plays a critical role in the response to hypovolemia, which 
has been demonstrated by Ward, Soller, and colleagues [7-9]. However, the exact 
response of the microcirculation with respect to (down)regulating microvascular 
density and perfusion and the consequent effects on peripheral tissue oxygenation 
and oxygen consumption for compensation of hypovolemia remains elusive.  
To evaluate the microcirculation under hypovolemic conditions, Ward et al., recently 
performed sidestream dark field (SDF) imaging during lower body negative pressure 
(LBNP) in healthy subjects [7]. LBNP reduces central blood volume, as demonstrated 
by several studies [10,11]. In agreement with earlier studies [8,9], application of LBNP 
resulted in a significant shift in blood volume from the upper to the lower body that 
was accompanied by a reduction in SV and allowed to study the effects of controlled 
central hypovolemia on the microcirculation. The authors found that microvascular 
density was significantly reduced by the application of LBNP [7]. However, the authors 
only reported on changes in microvascular density and did not describe the potential 
changes in microvascular flow. Therefore, although the study provided useful insight in 
the diffusion-related changes (microvascular density) in the microcirculation in response 
to hypovolemia, it lacked insight in the convection-related changes (microvascular 
perfusion). This is, however, a significant variable since downregulation of the 
microcirculation for maintenance of blood pressure potentially relies on two pathways; 
i.e., reducing microvascular density and reducing microvascular perfusion [12-15]. 
Furthermore, microcirculatory oxygen delivery relies on both microvascular density 
and microvascular perfusion [12]. That changes in microcirculatory perfusion could be 
important during hypovolemia has been shown by Dubin et al. who have identified 
that depressed sublingual and intestinal microcirculatory perfusion in hemorrhaged 
sheep was associated with intramucosal acidosis [16]. Furthermore, regional perfusion 
is regulated by, e.g., arterial and pulmonary baroreceptors, carotid sinus, and muscle 
sympathetic nerve activity in order to maintain perfusion of vital organs [17]. In this 
respect, application of LBNP leads to a shift from blood volume away from the upper 
body and thereby triggers the autonomic baroreflex activation [18]. 
Our group has recently employed near-infrared spectroscopy (NIRS) during LBNP to 
study peripheral tissue oxygenation under conditions of controlled central hypovolemia 
in a group of healthy volunteers [19]. In agreement with Soller et al. [8], we found that 
NIRS could be used to detect changes in peripheral tissue hemoglobin content (THI) 
and tissue oxygenation (StO2) consequent to central hypovolemia. To integratively 
assess the response of the microcirculation to controlled central hypovolemia, 
sublingual SDF imaging and NIRS in combination with a VOT were performed at 0 
and -60 mmHg LBNP in a subset of this group. SDF images were analyzed for total 
vessel density (TVD), perfused vessel density (PVD), and the microvascular flow 
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index (MFI) and flow heterogeneity (MFIhetero), thus, incorporating both diffusion- 
and convection-related microcirculatory parameters. VOT-derived NIRS traces were 
analyzed for parameters reflecting tissue oxygen consumption and post-occlusion 
microvascular reperfusion and hyperemia. Using this methodology we were able to 
test the hypothesis that controlled, adequately compensated, central hypovolemia 
(i.e. hypovolemia without severe hypotension) in subjects with intact autoregulation 
would be associated with decreased microcirculatory diffusion (TVD and PVD) and 
convection (MFI and MFIhetero) properties and, consequently, decreased tissue 
oxygen carrying capacity (THI) and tissue oxygenation (StO2). Furthermore, we aimed 
to evaluate the impact of hypovolemia-induced microcirculatory alterations on resting 
tissue oxygen consumption.
materials & methods
subjects
The sublingual SDF image acquisition and NIRS measurements in combination with 
a VOT performed at 0 and -60 mmHg LBNP were part of an experimental protocol 
described previously [19]. The study protocol was approved by the medical ethics 
committee of the Academic Medical Center of the University of Amsterdam. Written 
informed consent was obtained from all subjects and subjects refrained from the intake 
of vaso-active medication and intensive exercise prior to the experiment. In order to 
minimize possibly confounding factors such as gender, age and physical fitness, which 
contribute to different LBNP tolerances [11], we recruited a homogenous group of 
healthy male volunteers. Twenty-four healthy male subjects with a mean±standard 
error of the mean (SEM) age of 28±1 years, body weight of 82±2 kg, and height of 
182±1 cm volunteered for the study and passed an exercise electrocardiogram test 
and medical history questionnaire [19]. 
lower Body negative Pressure
The LBNP device and protocol have been described in detail elsewhere [19]. In brief, 
the lower body of participants was positioned in a negative pressure chamber and an 
airtight seal at the level of the iliac crest was applied. The LBNP protocol consisted 
of a 30 min baseline period at LBNP=0 mmHg followed by stepwise application of 
LBNP to -20, -40, and -60 mmHg. Thenar and forearm StO2 and THI values were 
continuously recorded and at baseline and at -60 mmHg LBNP, sublingual SDF 
images were acquired and a VOT was performed. The protocol could be immediately 
terminated by the physician in case of impending cardiovascular collapse or at the 
request of the subject. Impending cardiovascular collapse was defined by a drop in 
systolic blood pressure of > 15 mmHg from baseline blood pressure, bradycardia or 
if termination was requested by the subject due to dizziness, discomfort or nausea. 
An attending physician was present in the laboratory during all experiments to ensure 
safety of participants. 
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hemodynamic monitoring
To monitor hemodynamic changes induced by LBNP, the SV, HR, systemic vascular 
resistance (SVR), cardiac output (CO), and mean arterial pressure (MAP) were 
continuously and non-invasively measured throughout the entire protocol using 
volume clamp finger plethysmography (Nexfin, BMEYE, Amsterdam, the Netherlands). 
The finger cuff of the monitor was placed around the right middle finger and was kept 
at heart level. Nexfin and its predecessors have been intensively validated and have 
shown to provide reliable measurements of hemodynamic parameters [20-22]
sidestream dark field imaging
Sublingual microcirculatory density and perfusion were monitored using an SDF 
imaging device (Microvision Medical, Amsterdam, the Netherlands) at 0 (baseline) and 
-60 mmHg LBNP. A detailed description of the SDF technology is provided elsewhere 
[23]. Briefly, in SDF imaging, the tissue is illuminated with green light emitting 
diodes concentrically placed around the central microscope objective to provide 
SDF illumination. The lens system in the core of the objective is optically isolated 
from the illuminating outer ring to prevent image contamination by tissue surface 
reflections, which allows imaging of subsurface microcirculatory structures. The lens 
of the SDF device is covered by a sterile disposable cap (Microscan Lens, MicroVision 
Medical, Amsterdam, The Netherlands). The video microscope uses an x5 objective 
and monitors a mucosal area of 1.0 x 0.75 mm at a 720 x 567 pixel resolution and a 
frame rate of 25 Hz. 
SDF images were acquired by gently placing cap-covered imaging probe on 
the sublingual mucosal tissue. Care was taken to prevent pressure artifacts [24,25]. 
According to the round-the-table-conference guidelines, five different mucosal sites 
were measured per time point [26]. The obtained video sequences were stored on 
DVI tape and saved on a computer in DV-AVI file format and analyzed by two analysts 
(SAB and MR; blinded to the subject and time point) for total vessel density (TVD; mm 
vessel/mm2 image), perfused vessel density (PVD; mm perfused vessel/mm2 image), 
and the microvascular flow index (MFI; 0=no flow, 1=intermittent flow, 2=sluggish flow, 
3=normal flow) using a dedicated computer software package (Automated Vascular 
Analysis, Microvision Medical) [27,28]. The MFI score was calculated by averaging the 
MFI scores over four quadrants per image and 5 images per time point (=20 scores per 
time point per subject). The MFIhetero score was calculated as the highest MFI score 
minus the lowest MFI score, divided by the mean MFI score across all 20 MFI scores 
per time point per subject [24]. Microcirculatory analysis was confined to vessels with 
an average diameter below 25 µm.
near-infrared spectroscopy
Two InSpectra tissue spectrometers (Hutchinson Technology, Hutchinson, MN) 
were used to measure StO2 and THI on the left forearm and thenar continuously 
and non-invasively as described previously [19]. Both NIRS devices were equipped 
with a reflectance mode probe having a 1.5 mm optical fiber to illuminate tissue and 
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a 0.4 mm optical fiber to collect the backscattered light. The spacing between the 
illuminating fiber and the detection fiber was 15 mm and the NIRS measurement depth 
is estimated as half this probe spacing [29,30]. During the entire protocol, hand and 
forearm were kept at heart level and subjects were instructed to prevent movement 
of hand or arm. 
vascular occlusion test
During a VOT, which was performed at 0 (baseline) and -60 mmHg LBNP, the forearm 
and hand circulation is transiently stopped by arterio-venous occlusion induced by 
application of suprasystolic pneumatic pressure around the upperarm [31,32]. As 
demonstrated by Myers and colleagues, baseline StO2 represents the balance between 
oxygen delivery rate and the oxygen consumption rate, whereas THI measures the 
hemoglobin content in the NIRS measurement volume and represents the tissue 
oxygen carrying capacity [29,30]. Although related to the systemic hemoglobin 
content, THI is also influenced by microvascular density and tone [29,32]. In the 
absence of oxygen delivery (i.e., during vascular occlusion), the StO2 downslope 
provides an indication of the microcirculatory deoxygenation rate. Multiplication of 
the mean tissue oxygen carrying capacity (THI) and microcirculatory deoxygenation 
rate (StO2 downslope) provides an index for the resting tissue oxygen consumption 
rate per minute (iVO2= (THI bsln*StO2 blsn)-(THI min*StO2 min)/3), a method which 
corresponds to the method used by Skarda et al. [32]. After release of the occlusion, 
the StO2 upslope is considered to represent the microvascular reperfusion rate and the 
subsequent suprabaseline StO2 levels is considered to represent reactive hyperemia 
[33,34]. Hence, using a VOT in combination with NIRS allows the characterization of 
tissue oxygen consumption and microvascular reperfusion and reactivity. 
After a 2-min stabilization period  (baseline) at 0 and -60 mmHg LBNP, stagnant 
ischemia was induced for 3 min by rapidly inflating a pneumatic cuff (within 5 sec), 
placed around the upperarm, to 50 mmHg above systolic blood pressure. Subsequently, 
the cuff was deflated (within 1 sec) and StO2 measurements continued up to 5 min 
post-ischemia. Data were continuously saved on two computers and analyzed using 
InSpectra Analysis V3.3 software (Hutchinson Technology). The VOT-derived StO2 
traces were divided into four phases: baseline, ischemia, reperfusion, and hyperemia. 
The ischemic phase was analyzed for StO2 and THI downslope. The reperfusion phase 
was analyzed for StO2 and THI upslope and the hyperemic phase was analyzed for the 
StO2 and THI area under the hyperemic curve (AUC) [31].
data analysis
Data were plotted and analyzed using GraphPad Prism software (GraphPad Prism 
Software, San Diego, CA). Data are reported in median (25th-75th pct) in the tables 
and as percentage of baseline in the text. Comparative analysis of data sets between 
baseline and LBNP=-60 mmHg was performed using Wilcoxon matched pairs test. 
P<0.05 was considered statistically significant.
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results
Of the 24 subjects, 23 reached the LBNP=-60 mmHg level [19], but only 14 tolerated 
the LBNP=-60 mmHg step long enough to complete the VOT and SDF image 
acquisition. The hemodynamic parameters measured before and during application of 
LBNP in these subjects are presented in Table 1. 
Table 1. Hemodynamic parameters before and during application of lower body negative pressure 
(LBNP). Values are reported in median (25th-75th). 
lBnP=0 mmhg lBnP=-60 mmhg delta
(% of 
baseline)
p-value
Hemodynamic parameters
Stroke volume mL 117 (108-126) 77 (71-87) -34 0.001
Heart rate bpm 59 (52-66) 83 (76-88)  41 0.001
System vascular resistance AU 1063 (951-1136) 1153 (1020-1307)   8 0.035
Cardiac output L/min 6.8 (6.2-7.6) 6.0 (5.8-7.1) -13 0.033
Mean arterial pressure mmHg 92 (84-96) 93 (86-97)  1 0.230
LBNP of -60 mmHg induced a significant 34 % decrease in SV (p=0.001), which 
in turn, led to a significant 41 % increase in HR (p=0.001) and an 8 % increase in SVR 
(p=0.035). CO decreased by 13 % (p=0.033), but MAP was maintained around baseline 
level (p=0.230). Hence, LBNP caused a significant shift in blood volume from the upper 
to the lower body, which was accompanied by a decrease in SV and activation of 
compensatory mechanisms such as increased HR and SVR to maintain the MAP.
 The microcirculatory parameters derived from the SDF images obtained at 0 
(baseline) and -60 mmHg LBNP are presented in Table 2. Typical SDF images obtained 
at 0 and -60 mmHg LBNP are shown in Figure 1. LBNP induced a slight decrease in 
Table 2. Sidestream dark field (SDF) imaging parameters before and during application of lower body 
negative pressure (LBNP). Values are reported in median (25th-75th). 
lBnP=0 mmhg lBnP=-60 mmhg delta
(% of 
baseline)
p-value
Sidestream dark field (SDF) imaging parameters
Total vessel density mm/mm2 13.3 (12.7-14.2) 12.2 (11.6-13.7) -8 0.070
Perfused vessel density mm/mm2 13.2(12.5-14.1) 12.2 (11.5-13.6) -8 0.035
Portion of perfused vessels % 99 (98-100) 99 (97-99) 0 0.241
Microvascular flow index AU 3.0 (2.8-3.0) 2.8 (2.6-2.9) -7 0.014
Flow heterogeneity index AU 0.3 (0-0.4) 0.4 (0.4-0.8) 33 0.003
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TVD (8 %, p=0.070) and PVD (8 %, p=0.035). The portion of perfused vessels (=PVD/
TVD) remained unaltered (p=0.241). 
The MFI was also slightly decreased (7 %, p=0.014) as a result of LBNP and 
the MFIhetero was significantly increased (33 %, p=0.003). This indicates that both 
diffusion- and convection-related properties of the microcirculation are affected 
during controlled, adequately compensated, central hypovolemia.
The StO2 and THI parameters derived from the VOT performed before and during 
application of LBNP are presented in Table 3. Typical forearm StO2 traces during a 
VOT performed at 0 and -60 mmHg LBNP are shown in Figure 2. 
Figure 1. Typical sidestream dark field images of the sublingual microcirculation acquired at 0 (A) 
and -60 (B) mmHg lower body negative pressure. 
Table 3. Baseline and vascular occlusion test-derived tissue oxygen saturation (StO2) and tissue 
hemoglobin index (THI) parameters before and during application of lower body negative pressure 
(LBNP). Values are reported in median (25th-75th). 
lBnP=0 mmhg lBnP=-60 mmhg delta
(% of 
baseline)
p-value
Thenar StO2 and THI during the vascular occlusion test
StO2 baseline %  90 (84-91)  86 (84-89) -4 0.023
THI baseline AU 13.5 (12.7-14.6)  12.7 (12.0-14.1) -6 0.009
StO2 downslope %/min -10.5 (8.8-11.8) -10.3 (8.8-13.4)  2 0.542
THI downslope AU/min -0.95 (0.75-1.20) -1.03 (0.87-1.23)  8 0.542
iVO2 AU*%/min 135 (119-164)  134 (105-164) -1 1.000
StO2 upslope %/min 153 (91-183)  159 (138-174)  4 0.268
THI upslope AU/min 18 (15-22)  22 (17-26)  22 0.091
StO2 area under the curve %*min 11.6 (8.5-15.3)  14.3 (11.3-16.0)  23 0.426
THI area under the curve AU*min 3.9 (1.9-5.0)  4.4 (3.3-6.1)  13 0.104
Forearm StO2 and THI during the vascular occlusion test
StO2 baseline % 81 (73-85) 78 (70-81) -4 <0.001
THI baseline AU 6.8 (5.1-7.5) 5.8 (4.7-6.5) -15 <0.001
StO2 downslope %/min -7.9 (6.3-10.0) -10.1 (7.4-13.1) 28 0.042
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In the thenar, StO2 decreased by 4 % (p=0.023) and THI decreased by 6 % 
(p=0.009). In the forearm, StO2 decreased by 4 % (p<0.001) and THI decreased by 
15 % (p<0.001). In the thenar, VOT-derived StO2 and THI parameters did not change 
significantly NP (p=0.091). In the forearm, in contrast, all VOT-derived StO2 parameters 
changed significantly: StO2 downslope increased by 28 % (p=0.042), StO2 upslope 
increased by 13 % (p=0.049), and StO2 area under the hyperemic curve increased by 
47 % (p=0.025). The forearm THI downslope (p=0.890) and upslope (p=0.557) did not 
change significantly, but the THI AUC increased by 75 % (p<0.001). Although the StO2 
downslope increased by 28 %, the resting tissue oxygen consumption rate (iVO2) 
remained unaffected by application of LBNP (p=0.952), indicating the importance 
of combining StO2 and THI data for proper interpretation of the NIRS results with 
respect to the assessment of tissue oxygen consumption rate. Taking the VOT results 
into account, the forearm NIRS measurements were more sensitive to hypovolemia 
than the thenar NIRS measurements.  
Figure 2. Typical forearm tissue oxygen saturation (StO2) traces during a vascular occlusion test 
performed at 0 and -60 mmHg lower body negative pressure (LBNP). 
Table 3. (continued)
lBnP=0 mmhg lBnP=-60 mmhg delta
(% of 
baseline)
p-value
THI downslope AU/min -0.17 (0.10-0.53) -0.22 (0.12-0.41) -29 0.890
iVO2 AU*%/min 47 (31-62) 50 (39-69) 6 0.952
StO2 upslope %/min 137 (104-198) 155 (131-230) 13 0.049
THI upslope AU/min 8.4 (4.6-11.3) 12.0 (7.1-22.9) 43 0.577
StO2 area under the curve %*min 9.1 (6.1-11.0) 13.4 (9.9-17.4) 47 0.025
THI area under the curve AU*min 0.8 (0.6-1.6) 1.4 (1.0-2.4) 75 <0.001
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discussion
The aim of this study was to test the hypothesis that controlled, adequately 
compensated, central hypovolemia in subjects with intact autoregulation would be 
associated with decreased microcirculatory diffusion (TVD and PVD) and convection 
(MFI and MFIhetero) properties and, consequently, decreased tissue oxygen carrying 
capacity (THI) and tissue oxygenation (StO2). Furthermore, we aimed to evaluate 
the impact of hypovolemia-induced microcirculatory alterations on resting tissue 
oxygen consumption. To this end, we performed sublingual SDF imaging and NIRS in 
combination with a VOT in an LBNP model. To compensate for the central hypovolemia 
induced by LBNP, both HR and SVR increased, in agreement with studies by Convertino 
et al. [5-9]. In general, the increased HR and SVR compensated adequately for the 
decreased SV and maintained the MAP around baseline level during the entire LBNP 
protocol. It must be noted, however, that cardiovascular collapse (i.e., rapid decline 
of MAP) was not included in the analysis as this fell out of the scope of the study. The 
primary findings of the present study were that controlled, adequately compensated, 
central hypovolemia led to: 1) significantly decreased sublingual microvascular 
density (PVD) and perfusion (MFI and MFIhetero) and consequently, 2) significantly 
decreased tissue oxygen carrying capacity (THI) and tissue oxygenation (StO2); and 3) 
an unaltered resting tissue oxygen consumption rate (iVO2). 
One of the findings in the present study was that both diffusion- and convection-
related properties of the microcirculation are affected during hypovolemia; i.e., both 
microvascular density (PVD) and perfusion (MFI and MFIhetero) were significantly 
affected by application of LBNP. The decreased microvascular density during 
application of LBNP confirms the findings in an earlier study by Ward et al. where 
SDF images obtained during LBNP were analyzed for PVD [7]. In that study, however, 
the authors did not analyze alterations in microcirculatory flow characteristics, which 
is potentially a significant variable since microcirculatory oxygen delivery relies on 
both microvascular density and microvascular perfusion and downregulation of the 
microcirculation for maintenance of blood pressure might affect one or both of 
these microcirculatory properties [12-15]. Activation of the autonomic baroreflex by 
the reduction in upper body blood volume consequent to the application of LBNP 
leads to a downregulation of the peripheral microcirculation by increasing peripheral 
vascular resistance. Although we have not measured muscle sympathetic nerve activity 
and/or baroreceptor receptors in the present study, previous research by others 
has demonstrated that application of LBNP results in several effects on cardiac and 
arterial receptors [35] and stimulus of the arterial and pulmonary receptors leads to 
peripheral vasoconstriction [36]. These findings support the observed decrease in both 
microcirculatory diffusion and convection in response to the reduced macrocirculatory 
volume in the upper body.  
Sublingual SDF imaging has been used in many clinical scenarios, including 
cardiogenic shock, sepsis, and surgery [37-40]. Dubin et al., furthermore, have shown 
that depressed microcirculatory perfusion in hemorrhaged sheep was associated with 
intramucosal acidosis, emphasizing the relevance of alterations in microcirculatory 
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perfusion in hypovolemia [16]. These studies therefore underscore the relevance of 
sublingually-obtained parameters of microvascular density and perfusion.
In addition to the decreased microvascular density (PVD) and mean microcirculatory 
flow (MFI), we found that microcirculatory flow was heterogeneously affected by LBNP 
as indicated by the increased MFIhetero. In a recent study by Trzeciak et al., early 
sublingual microcirculatory perfusion derangements were studied in patients with 
severe sepsis/septic shock [24]. In the present study, the MFIhetero score at LBNP=0 
mmHg is similar to the score reported by Trzeciack et al. for the healthy control subjects 
and the MFIhetero score at LBNP=-60 mmHg is similar to the score for the surviving 
patients. Trzeciak et al. further reported that non-surviving patients had an MFIhetero 
score twice as high as the surviving patients [24], underlining the pathophysiological 
relevance of this parameter. 
It is important to note that the NIRS measurement comprises arteriolar, capillary, 
and venular blood. Since LBNP leads to a reduction in microvascular density and 
perfusion, which is regulated at the arterial/arteriolar side of the microcirculation, the 
contribution of this side to the NIRS signal most likely decreases during LBNP. This 
would lead to a reduction in StO2 as observed in the present study. The reduction in 
microcirculatory density and perfusion was reflected by the decreased steady-state 
(i.e., baseline) StO2 and THI values during application of LBNP as presented previously 
by us [19] and others [7-9]. A potential physiological explanation for the difference 
between the thenar and forearm in terms of sensitivity to hypovolemia is that the 
circulation in the hands might be well-preserved during cardiovascular challenges such 
as the activation of the baroreflex during application of LBNP. This is also observed, 
for instance, during severe hypothermia where a phenomenon termed cold-induced 
vasodilation opens the (micro)circulation to the hands in order to prevent cold-induced 
necrosis and thereby increase the chances of survival [41]. However, whether such a 
response would actually overrule the baroreflex remains unknown.
Although Soller et al. also found a reduction in forearm StO2 with increasing LBNP, 
care should be taken when comparing StO2 values. The values we present here are 
significantly higher than those presented by Soller et al, probably because different 
NIRS devices were used, as explained in more detail in [8]. Furthermore, in the studies 
where Soller et al employed the same NIRS device as we have done here, the probes 
were placed in the thenar and not on the forearm. Similarly to the findings in the 
present study, the authors reported no significant differences in StO2 and THI baseline 
values in the thenar. In the forearm, in contrast, the authors report on a significant 
reduction in NIRS parameters, although measured using different NIRS technology. 
Hence, the observed reduction forearm StO2 and THI in response to application of 
LBNP in both studies is comparable, demonstrating the sensitivity of this application 
site in healthy volunteers. 
In the present study we applied a VOT to measure potential alterations in tissue 
oxygen consumption and showed that this was maintained even though steady-
state microcirculatory oxygenation was reduced. Our finding of maintained oxygen 
consumption measured locally in the forearm and thenar tissue is in agreement of the 
observations by Ward et al. on maintained systemic oxygen consumption during LBNP 
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[7]. Considering the extent of the observed hypovolemia-induced microcirculatory 
alterations and the low basal oxygen consumption rate of the resting skeletal muscle, 
this is not a very surprising result [42]. 
In this light, it is important to realize that LBNP is a model of controlled central 
hypovolemia rather than a model simulating hemorrhage-induced hypovolemia. 
In hemorrhage, both coagulation and inflammation pathways are activated which 
significantly affect microvascular function [4]. Using an LBNP model, we were successful 
in studying the microcirculatory response to controlled, adequately compensated, 
central hypovolemia in case of intact autoregulation. Hence, we have delineated 
the microcirculatory alterations in response to (central) hypovolemia from the 
microcirculatory alterations in response to activation of coagulation and inflammation 
pathways. The results we present, however, are therefore not directly applicable in 
hypovolemic patients where microvascular function might be compromised due to 
the underlying pathophysiological conditions.  In line, the present study therefore 
underscores the major roles of inflammation and coagulation disorders and shows 
that hypovolemia is only minimally responsible for the depressed microcirculation 
observed in critically ill patients. 
The THI represents the amount of hemoglobin present in the NIRS measurement 
volume, which depends on both the systemic hemoglobin level and the peripheral 
(micro)vascular tone. As hemoglobin is the only source of oxygen for the tissue cells 
(myoglobin deoxygenation occurs at much lower saturations), the THI reflects the 
tissue oxygen carrying capacity. The StO2 downslope, on the other hand, represents 
the rate at which the hemoglobin present in the NIRS measurement volume 
deoxygenates during ischemia. Hence, if less hemoglobin would be present in the 
tissue, deoxygenation of the hemoglobin would be more rapidly, leading to a steeper 
StO2 downslope. The StO2 downslope in the ischemic phase of the VOT (i.e., during 
vascular occlusion), which reflects the microcirculatory deoxygenation rate, is steeper 
during application of LBNP. This did not mean that the tissue oxygen consumption 
rate was higher. Indeed, if one would only measure the StO2 downslope and interpret 
this as a measure of tissue oxygen consumption rate, erroneous conclusions could 
be drawn since the tissue oxygen carrying capacity (THI) could change between two 
measurement time points. This is exemplified in the present study where the StO2 
downslope increased by 28 % while the resting tissue oxygen consumption remained 
unaffected by application of LBNP. Since oxygen consumption is not limited by 
the amount of available oxygen and the diffusion of oxygen is a passive process, 
maintained oxygen consumption under conditions of reduced oxygen delivery directly 
reduces the StO2. Here we thus demonstrate that multiplication of the tissue oxygen 
carrying capacity (THI) by the microcirculatory deoxygenation rate (StO2 downslope) 
is required to find an index for the resting tissue oxygen consumption rate (iVO2) and 
that combining StO2 and THI data is key for proper interpretation of NIRS results 
under compromised circulatory conditions. However, it is important to point out that 
this method of calculating oxygen consumption has not been validated in humans and 
should be interpreted with care.
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additional findings
During vascular occlusion, a slight decrease in THI (THI downslope) was observed that 
could reflect ischemia-induced vasoconstriction that caused redistribution of blood from 
the microcirculation to the larger vasculature, thereby eliminating this blood from the 
NIRS measurement vasculature. The THI downslope did not change during our LBNP 
protocol, but could perhaps be affected under pathophysiological conditions where 
(micro)vascular regulation (and thus ischemia-induced vasoconstriction) is disturbed.
The post-occlusion StO2 and THI upslope and AUC are considered to be 
parameters reflecting microvascular reperfusion and reactive hyperemia, respectively 
[31-34]. We have shown that the upslope and AUC were unaltered in the thenar 
and increased in the forearm. This discrepancy could be caused by different volume 
re-distribution to the different compartments, which requires further research. The 
increase in microvascular reperfusion and reactivity in the present study is probably 
explained by the decreased baseline StO2 and increased StO2 downslope as a result 
of LBNP-induced hypovolemia, which led to an increased ischemic hit during vascular 
occlusion [43]. This, in turn, triggered excessive reactive hyperemia in our healthy 
volunteers with intact vasoregulatory mechanisms [33,34]. However, it must be noted 
that the (patho)physiological mechanisms underlying (alterations in) StO2 and THI 
upslope and AUC warrant further study.
study limitations
We acknowledge that the present study design has an important limitation being 
that it consists of only two time points, whereas more time points could show a trend 
in hypovolemia-related alterations in SDF imaging and NIRS-derived parameters. 
However, the time required for SDF image acquisition at five sublingual sites plus the 
VOT does not allow multiple time points due to the duration-dependent tolerance for 
LBNP [11]. Furthermore, other techniques for monitoring microvascular flow, such as 
laser Doppler velocimetry, were not included in the present study. As the alterations 
in microcirculatory density and perfusion as measured using SDF imaging were of 
modest extent, inclusion of other techniques could potentially provide additional 
information on the microcirculatory response to application of LBNP. Nonetheless, with 
the present study design we were able to detect significant alterations in SDF imaging 
parameters of microvascular density and perfusion and NIRS-derived parameters of 
tissue oxygenation, microvascular reperfusion, and reactive hyperemia.  
conclusions
By integrative assessment of microcirculatory alterations in response to controlled 
central hypovolemia using SDF, NIRS, and the VOT, we confirmed our study hypothesis 
that controlled, adequately compensated, central hypovolemia in subjects with intact 
autoregulation would be associated with decreased microcirculatory diffusion (PVD) 
and convection (MFI and MFIhetero) properties and, consequently, decreased tissue 
oxygen carrying capacity (THI) and tissue oxygenation (StO2). Using a VOT, moreover, 
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we showed that resting tissue oxygen consumption was maintained under conditions 
of adequately compensated central hypovolemia. We found that combining StO2 and 
THI data is key for the proper interpretation of the NIRS results with respect to the 
assessment of tissue oxygen consumption rate and that forearm NIRS measurements 
are more sensitive to hypovolemia compared to thenar NIRS measurements, both 
with and without a VOT. This is, to our knowledge, the first study linking parameters 
of microvascular density (TVD and PVD) and perfusion (MFI and MFIhetero) obtained 
using SDF imaging to parameters of tissue oxygen carrying capacity (THI) and tissue 
oxygenation (StO2) obtained using NIRS during controlled central hypovolemia. 
Moreover, this is the first study analyzing both StO2 and THI dynamics during a VOT. 
acknowledgments
The employed NIRS devices were provided by Hutchinson Technologies Inc (HT). This 
study was in part supported by a grant from HT. HT had no part in the study design, 
data analysis, or drafting of the manuscript. 
69
SD
F, N
IR
S, A
N
D
 V
O
T D
U
R
IN
G
 LB
N
P
III
reFerences
1. Kauvar DS, Lefering R, Wade CE. Impact of 
hemorrhage on trauma outcome: an over-
view of epidemiology, clinical presentations, 
and therapeutic considerations. J Trauma 
2006; 60(6 Suppl) S3-11.
2. Kauvar DS, Wade CE. The epidemiology and 
modern management of traumatic hemor-
rhage: US and international perspectives. 
Crit Care 2005; 9(Suppl 5):S1-9.
3. Moore FA, McKinley BA, Moore EE. The next 
generation in shock resuscitation. Lancet 
2004; 363:1988-96.
4. Angele MK, Schneider CP, Chaudry IH. 
Bench-to-bedside review: latest results in 
hemorrhagic shock. Crit Care 2008; 12:218.
5. Convertino VA, Ludwig DA, Cooke WH. 
Stroke volume and sympathetic responses 
to lower-body negative pressure reveal new 
insight into circulatory shock in humans. 
Auton Neurosci 2004; 111:127-34.
6. Cooke WH, Ryan KL, Convertino VA. Lower 
body negative pressure as a model to study 
progression to acute hemorrhagic shock in 
humans. J Appl Physiol 2004; 96:1249-61.
7. Ward KR, Tiba MH, Ryan KL, Filho IP, Rickards 
CA, Witten T, Soller BR, Ludwig DA, Conver-
tino VA. Oxygen transport characterization 
of a human model of progressive hemor-
rhage. Resuscitation 2010; 81:987-93.
8. Soller BR, Ryan KL, Rickards CA, Cooke WH, 
Yang Y, Soyemi OO, Crookes BA, Heard SO, 
Convertino VA. Oxygen saturation deter-
mined from deep muscle, not thenar tissue, 
is an early indicator of central hypovolemia 
in humans. Crit Care Med 2008; 36:176-82.
9. Soller BR, Yang Y, Soyemi OO, Ryan KL, Rick-
ards CA, Walz JM, Heard SO, Convertino VA. 
Noninvasively determined muscle oxygen 
saturation is an early indicator of central 
hypovolemia in humans. J Appl Physiol 
2008; 104:475-81.
10. Wolthuis RA, Bergman SA, Nicogossian 
AE. Physiological effects of locally applied 
reduced pressure in man. Physiol Rev 1974; 
54:566-95.
11. Goswami N, Loeppky JA, Hinghofer-Szalkay 
H. LBNP: past protocols and technical 
considerations for experimental design. 
Aviat Space Environ Med 2008; 79:459-71.
12. De Backer D, Ospina-Tascon G, Salgado D, 
Favory R, Creteur J, Vincent JL. Monitoring 
the microcirculation in the critically ill patient: 
current methods and future approaches. 
Intensive Care Med 2010; 36:1813-25.
13. Borgström P, Bruttig SP, Lindbom L, Inta-
glietta M, Arfors KE. Microvascular responses 
in rabbit skeletal muscle after fixed volume 
hemorrhage. Am J Physiol 1990; 259: 
H190-96.
14. Kerger H, Waschke KF, Ackern KV, Tsai AG, 
Intaglietta M. Systemic and microcirculatory 
effects of autologous whole blood resusci-
tation in severe hemorrhagic shock. Am J 
Physiol 1999; 276:H2035-43.
15. Lundy DJ, Trzeciak S. Microcirculatory 
dysfunction in sepsis. Crit Care Clin 2009; 
25:721-31, viii.
16. Dubin A, Pozo MO, Ferrara G, Murias G, 
Martins E, Canullán C, Canales HS, Kanoore 
Edul VS, Estenssoro E, Ince C. Systemic and 
microcirculatory responses to progressive 
hemorrhage. Intensive Care Med 2009; 
35:556-64.
17. Ichinose M, Saito M, Fujii N, Kondo N, Nishi-
yasu T. Modulation of the control of muscle 
sympathetic nerve activity during severe 
orthostatic stress. J Physiol 2006; 576: 
947-58.
18. Saitoh T, Ogawa Y, Aoki K, Shibata S, Otsubo 
A, Kato J, Iwasaki K. Bell-shaped relationship 
between central blood volume and sponta-
neous baroreflex function. Auton Neurosci 
2008; 143:46-52.
19. Bartels SA, Bezemer R, Wallis de Vries FJ, 
Milstein DMJ, Lima A, Cherpanath TGV, van 
den Meiracker AH, van Bommel J, Heger M, 
Karemaker JM, Ince C. Multi-site and multi-
depth near-infrared spectroscopy in a model 
of simulated (central) hypovolemia: lower 
body negative pressure. Intensive Care Med 
2011; 37:671-7.
20. Wesseling KH, Settels JJ, van der Hoeven 
GM, Nijboer JA, Butijn MW, Dorlas JC. 
Effects of peripheral vasoconstriction on the 
measurement of blood pressure in a finger. 
Cardiovasc Res 1985; 19:139-45.
21. Parati G, Casadei R, Groppelli A, Di Rienzo 
M, Mancia G. Comparison of finger and 
intra-arterial blood pressure monitoring at 
rest and during laboratory testing. Hyperten-
sion 1989; 13:647-55.
22. Imholz BP, Settels JJ, van der Meiracker AH, 
Wesseling KH, Wieling W. Non-invasive 
continuous finger blood pressure measure-
ment during orthostatic stress compared to 
70
III
intra-arterial pressure. Cardiovasc Res 1990; 
24:214-21.
23. Goedhart PT, Khalilzada M, Bezemer R, 
Merza J, Ince C. Sidestream Dark Field (SDF) 
imaging: a novel stroboscopic LED ring-
based imaging modality for clinical assess-
ment of the microcirculation. Opt Express 
2007; 15:15101-14.
24. Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi 
M, Bajaj J, Abate NL, Arnold RC, Colilla S, 
Zanotti S, Hollenberg SM. Early microcircula-
tory perfusion derangements in patients with 
severe sepsis and septic shock: relationship 
to hemodynamics, oxygen transport, and 
survival. Ann Emerg Med 2007; 49:88-98.
25. Balestra GM, Bezemer R, Boerma EC, Yong 
ZY, Sjauw KD, Engstrom AE, Koopmans M, 
Ince C. Improvement of sidestream dark field 
imaging with an image acquisition stabilizer. 
BMC Med Imaging 2010; 13:10:15.
26. De Backer D, Hollenberg S, Boerma C, 
Goedhart P, Büchele G, Ospina-Tascon G, 
Dobbe I, Ince C. How to evaluate the micro-
circulation: report of a round table confer-
ence. Crit Care 2007; 11:R101.
27. Boerma EC, Mathura KR, van der Voort PH, 
Spronk PE, Ince C. Quantifying bedside-
derived imaging of microcirculatory abnor-
malities in septic patients: a prospective 
validation study. Crit Care 2005; 9:R601-606.
28. Dobbe JG, Streekstra GJ, Atasever B, 
van Zijderveld R, Ince C. Measurement of 
functional microcirculatory geometry and 
velocity distributions using automated 
image analysis. Med Biol Eng Comput 2008; 
46:659-70.
29. Myers DE, Anderson LD, Seifert RP, Ortner 
JP, Cooper CE, Beilman GJ, Mowlem 
JD. Noninvasive method for measuring 
local hemoglobin oxygen saturation in 
tissue using wide gap sec derivative near-
infrared spectroscopy. J Biomed Opt 2005; 
10:034017.
30. Myers D, McGraw M, George M, Mulier K, 
Beilman G. Tissue hemoglobin index: a 
non-invasive optical measure of total tissue 
hemoglobin. Crit Care 2009; 13(Suppl 5):S2.
31. Bezemer R, Lima A, Myers D, Klijn E, Heger 
M, Goedhart PT, Bakker J, Ince C.  Assess-
ment of tissue oxygen saturation during a 
vascular occlusion test using near-infrared 
spectroscopy: the role of probe spacing and 
measurement site studied in healthy volun-
teers. Crit Care 2009; 13(Suppl 5):S4.
32. Skarda DE, Mulier KE, Myers DE, Taylor 
JH, Beilman GJ. Dynamic near-infrared 
spectroscopy measurements in patients 
with severe sepsis. Shock 2007; 27: 
348-53.
33. Creteur J, Carollo T, Soldati G, Buchele G, De 
Backer D, Vincent JL. The prognostic value 
of muscle StO2 in septic patients. Intensive 
Care Med 2007; 33:1549-56.
34. Doerschug KC, Delsing AS, Schmidt GA, 
Haynes WG. Impairments in microvas-
cular reactivity are related to organ failure 
in human sepsis. Am J Physiol Heart Circ 
Physiol 2007; 293:H1065-71.
35. Rea RF, Wallin BG. Sympathetic nerve activity 
in arm and leg muscles during lower body 
negative pressure in humans. J Appl Physiol 
1989; 66:2778–81.
36. Watenpaugh DE, Breit GA, Buckley TM, 
Ballard RE, Murthy G, Hargens AR. Human 
cutaneous vascular responses to whole-
body tilting, Gz centrifugation, and LBNP. J 
Appl Physiol 2004; 96:2153-60.
37. Den Uil CA, Lagrand WK, van der Ent M, 
Jewbali LS, Cheng JM, Spronk PE, Simoons 
ML. Impaired microcirculation predicts poor 
outcome of patients with acute mycocardial 
infarction complicated by cardiogenic shock. 
Eur Heart J 2010; 31:3032-9.
38. Kaluski E, Milo-Cotter O, Cotter G. Death 
and life are in the power of the tongue. 
Cardiology 2009; 114:39-41.
39. De Backer D, Creteur J, Preiser JC, Dubois 
MJ, Vincent JL. Microvascular blood flow is 
altered in patients with sepsis. Am J Respir 
Crit Care Med 2002; 166:98-104.
40. Jhanji S, Lee C, Watson D, Hinds C, Pearse 
RM. Microvascular flow and tissue oxygen-
ation after major abdominal surgery: asso-
ciation with postoperative complications. 
Intensive Care Med 2009; 35:671-7.
41. Daanen HA. Finger cold-induced vasodi-
lation: a review. Eur J Appl Physiol 2003; 
89:411-26.
42. George ME, Beilman GJ, Mulier KE, Myers 
DE, Wasiluk KR. Noninvasive tissue oxygen 
saturation measurements identify supply 
dependency.  J Surg Res 2010; 160:40-6.
43. Payen D, Luengo C, Heyer L, Resche-Rigon 
M, Kerever S, Damoisel C, Losser MR. Is 
thenar tissue hemoglobin oxygen satura-
tion in septic shock related to macrohemo-
dynamic variables and outcome? Crit Care 
2009; 13(Suppl 5):S6.


S. A. Bartels#, R. Bezemer#, F. J. Wallis de Vries, D. M.J. Milstein, A. Lima, 
T.G.V. Cherpanath, A.H. van den Meiracker, J. van Bommel, M. Heger,  
J.M. Karemaker, C. Ince
#These authors contributed equally to this work
Intensive Care Med 2011; 37(4):671-7
multi-site and multi-dePth near- 
inFrared sPectroscoPy in a model  
oF simulated (central) hyPovolemia:  
lower Body negative Pressure
IV
74
IV
aBstract
To test the hypothesis that the sensitivity of near-infrared spectroscopy (NIRS) to reflect 
the degree of (compensated) hypovolemia would be affected by the application site 
and probing depth. We simultaneously applied multi-site (thenar and forearm) and 
multi-depth (15-2.5 mm and 25-2.5 mm probe distance) NIRS in a model of simulated 
hypovolemia: lower body negative pressure (LBNP). 
Twenty-four healthy male volunteers were subjected to an LBNP protocol in which 
a baseline (bsln) period of 30 minutes was followed by a stepwise manipulation of 
negative pressure from 0 to -20, -40, -60, -80, and -100 mmHg (5 min per step). Stroke 
volume and heart rate were measured using volume-clamp finger plethysmography. 
Two multi-depth NIRS devices were used to measure tissue oxygen saturation (StO2) 
and tissue hemoglobin index (THI) continuously in the thenar and the forearm. To 
monitor the shift of blood volume towards the lower extremities, calf THI was measured 
by single-depth NIRS.
The main findings were that the application of LBNP resulted in a significant 
reduction in stroke volume which was accompanied by a reduction in forearm StO2 
and THI.
In conclusion, NIRS can be used to detect changes in StO2 and THI consequent to 
central hypovolemia. Forearm NIRS measurements are more sensitive to hypovolemia 
than thenar NIRS measurements. The sensitivity of these NIRS measurements does not 
depend on NIRS probing depth. The LBNP-induced shift of blood volume is reflected 
by the decreased THI in the forearm and an increased THI in the calf.
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introduction
Hypovolemia is a major complication occurring in numerous clinical scenarios 
involving civilian, combat, and disaster field traumas, surgical injuries, and intensive 
care settings [1-2]. The reduction in stroke volume (SV) associated with hypovolemia 
is physiologically countered by compensatory mechanisms such as increasing heart 
rate (HR) and systemic vascular resistance (SVR) to prevent the consequent decrease 
in blood pressure (BP) and organ perfusion. When these mechanisms fail, however, 
BP will fall and adequate perfusion of vital organs will be at risk. Hence, detection of 
hypovolemia before BP falls is of prime importance to initiate and/or guide treatment 
strategies aimed at maintaining adequate cardiac output (CO) and BP in the prevention 
of organ hypoperfusion [3-4]. 
To this end, near-infrared spectroscopy (NIRS) has been widely explored, successfully 
and unsuccessfully, for measuring tissue oxygen saturation (StO2) and an index for 
tissue hemoglobin content (THI) in attempts to identify the presence and severity of 
hypovolemia [5-10]. However, the main problem with the interpretation of NIRS data 
from these studies is the diversity of methodologies used for the assessment of StO2 
and THI. Two critical aspects concerning the methodology have been identified: the 
application site and the probing depth [7,10]. The application site is important as 
differences may exist in the sensitivity of underlying muscle groups and other tissues 
to cardiovascular challenges such as central hypovolemia. In addition, the probing 
depth, which correlates directly with the NIRS probe size, determines the relative 
contribution of muscular and (sub)dermal tissue to the NIRS measurement [7,10]. 
In an attempt to evaluate the detection of hypovolemia using NIRS, NIRS has 
recently been employed in a lower body negative pressure (LBNP) model of simulated 
central hypovolemia. Thenar StO2 was measured using a second-derivative NIRS device 
equipped with a 15 mm probe and forearm StO2 was measured using a multi-depth 
NIRS device equipped with a 30 mm probe [8]. No change in StO2 in the thenar was 
found, while forearm StO2 significantly decreased. It was suggested that the forearm 
was a superior application site for the detection of hypovolemia compared to thenar 
and that the 15 mm probe size was too small to collect light from a sufficiently deep 
layer of muscular tissue and thus not able to detect hypovolemia. We criticized the 
applied methodology because the thenar and forearm measurements were performed 
in separate experiments rather than simultaneously and because the study did not 
investigate the effects of the 15 mm probe on the forearm or of the 30 mm probe on 
the thenar [12]. Consequently, whether the superior detection of hypovolemia in the 
forearm was due to a more sensitive application site or due to greater probing depth 
remained inconclusive.  
The aim of the present study was to test the hypothesis that the sensitivity of 
near-infrared spectroscopy (NIRS) to reflect the degree of (compensated) hypovolemia 
would be affected by the application site and probing depth. For this purpose, we 
simultaneously applied multi-site (thenar and forearm) and multi-depth (15 mm and 25 
mm probe) NIRS during LBNP as a model of central hypovolemia.
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materials and methods
subjects
Twenty-four healthy male volunteers participated in this study. The study guidelines 
and procedures were reviewed and approved by the Medical Ethics Committee of the 
Academic Medical Center of the University of the Amsterdam and voluntary written 
informed consent was obtained from all subjects. All participants were screened by a 
cardiologist, underwent an exercise electrocardiogram (ECG test), and completed a 
medical history questionnaire prior to inclusion. All subjects were instructed to refrain 
from caffeine intake and other autonomic stimulants and to abstain from excessive 
physical labor >8 hours prior to the LBNP experiment. 
lBnP protocol and measurements 
In brief, the LBNP protocol consisted of a baseline period of 30 min followed by 
stepwise manipulation of negative pressure from 0 to -20, -40, -60, -80, and -100 
mmHg (5 min per step). The LBNP protocol could immediately be terminated by 
the subject or attending physician in case of impending cardiovascular collapse or 
per request of the subject. Cardiovascular and NIRS parameters were recorded at 
the end of each LBNP step and just before the onset of cardiovascular collapse. To 
monitor the shift of blood volume away from the upper body, thoracic bioimpedance 
(NICOM, Cheetah Medical Inc., Wilmington, DE) was used to measure thoracic fluid 
content (TFC) which was expected to decrease when blood is shifted away from the 
upper body [13-15]. Additionally, to monitor the shift of blood volume towards the 
lower body, a single-depth 15 mm NIRS probe (InSpectra, Hutchinson Technology, 
Hutchinson, MN) was placed on the medial soleus of the left calf to monitor the calf 
THI which was expected to increase when blood is shifted towards the lower body 
[9]. To monitor the physiological changes associated with LBNP, CO, SV, HR, mean 
arterial pressure (MAP), and SVR were continuously and non-invasively measured 
using volume-clamp finger plethysmography (Nexfin monitor, BMEYE, Amsterdam, 
the Netherlands) [16-18]. Multi-depth NIRS was employed to measure StO2 and THI in 
the thenar and forearm during LBNP. Both the StO2 and the THI calculation from the 
NIRS signal have been validated by Myers et al. [19-23]. Two multi-depth NIRS devices 
(InSpectra, Hutchinson Technology, Hutchinson, MN) were used to measure StO2 and 
THI continuously and non-invasively in the left thenar eminence and in the lateral side 
of the anterior surface of the left forearm, as described previously [11,21]. We refer to 
the NIRS measurements performed on the forearm and thenar with the 15 mm and 25 
mm probe spacing as F15, F25, T15, and T25, respectively. 
statistical analysis 
Data plotting and analysis were performed in GraphPad Prism software (GraphPad 
Software, San Diego, CA, USA). Data are presented as mean±standard error of the 
mean (SEM) after the normal distribution of the data was confirmed by D’Agostino 
and Pearson normality tests. First TFC, calf THI, and SV were plotted versus the level 
of LBNP and statistical significance of differences between LBNP levels was analyzed 
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using a one-way analysis of variance (ANOVA) for repeated measurements with a 
Bonferroni post-hoc test. P<0.05 was considered statistically significant. Second, 
all data were normalized and expressed as percentage of baseline value (bsln). As 
the decrease in SV consequent to LBNP is the primary stimulus for physiological 
compensatory mechanisms to be activated (e.g., increased HR and SVR), the data 
were plotted versus SV [% of bsln] and, to allow statistical analysis using ANOVA, data 
were categorized according to the following pre-defined categories: SV=100 % of 
bsln, SV=100-80 % of bsln, SV=80-60 % of bsln, and SV=60-40 % of bsln. Furthermore, 
Pearson’s correlation analysis was performed for forearm StO2 [% of blsn] and THI [% 
of blsn] versus SV [% of blsn].
results
subject characteristics
Since the tolerance of subjects to LBNP and the extent of the cardiovascular responses 
depend, amongst other factors, on age, physical fitness, gender, body size, and 
hydration status [24-29], a homogenous subject population was recruited for this 
study. The study population consisted of 24 male subjects with a mean±SEM age of 
28±1 years, body weight of 82±2 kg, and height of 182±1 cm. 
lBnP-induced blood volume shift and stroke volume reduction
All 24 subjects completed the LBNP=-20 and -40 mmHg steps, 23 subjects completed 
the LBNP=-60 mmHg step, 15 subjects completed the LBNP=-80 mmHg step, and 9 
subjects completed the LBNP=-100 mmHg step. Figure 2 shows that in all subjects, 
TFC decreased significantly (p<0.05) and calf THI increased significantly (p<0.05) 
with increasing LBNP. The decrease in TFC was associated a significant decrease in 
Figure 1. A subject placed in the lower body negative pressure 
chamber.
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SV (P<0.05). As the decrease in SV consequent to LBNP was the primary trigger for 
compensatory mechanisms activation, data were categorized according to SV=100 % 
of bsln (n=24), SV=100-80 % of bsln (n=36), SV=80-60 % of bsln (n=34), and SV=60-40 
% (n=25). 
hemodynamic response
In response to the decrease in SV, HR and SVR increased. At mild central hypovolemia 
induced by LBNP, HR remained unchanged (p>0.05), but when hypovolemia 
progressed, HR increased significantly (p<0.05). SVR increased significantly (p<0.05) 
from baseline to mild central hypovolemia, but remained unchanged (p>0.05) 
during further reduction of SV. During the entire LBNP protocol, with exclusion of 
cardiovascular collapse, CO and MAP maintained around baseline level (p>0.05).
multi-site and multi-depth nirs
All NIRS results, expressed as percentage of baseline value, are shown in Figure 3. 
In general, forearm NIRS measurements are more sensitive to reflect changes in SV 
than thenar NIRS measurements and the sensitivity of these measurements does not 
depend on the NIRS probing depth. Where HR did not show a significant change in the 
first SV category of SV=100-80 % of bsln, forearm and thenar StO2 and THI did for both 
probing depths. However, changes measured on the thenar were of marginal extent. 
discussion 
In the present study we have simultaneously applied multi-site and multi-depth NIRS to 
test the hypothesis that the sensitivity of NIRS to reflect the degree of (compensated) 
hypovolemia would be affected by the application site and probing depth. The main 
findings were that 1) the application of LBNP resulted in a significant shift in blood 
volume from the upper body to the lower body accompanied by a reduction in SV, 
Figure 2. A) Thoracic fluid content (TFC) and calf tissue hemoglobin index (THI), and B) stroke 
volume (SV) during stepwise increase of lower body negative pressure (LBNP), normalized and 
expressed as percentage of baseline (bsln). * p<0.05 versus LBNP = 0 mmHg and # p<0.05 
versus previous LBNP step.
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2) this SV reduction consequent to LBNP was countered by an increase in HR and 
SVR, which adequately compensated for the decrease in SV and maintaining CO and 
MAP near baseline level, 3) NIRS can be used to detect changes in peripheral tissue 
oxygenation (StO2) and hemoglobin content (THI) consequent to central hypovolemia, 
4) forearm NIRS measurements are more sensitive to LBNP-induced hypovolemia than 
thenar NIRS measurements, 5) the sensitivity of these NIRS measurements does not 
depend on NIRS probing depth, and 6) the LBNP-induced shift of blood volume from 
the upper body to the lower body is reflected by the decreased THI in the forearm and 
an increased THI in the calf.
To compensate for the central hypovolemia induced by LBNP, both HR and SVR 
increased. Initially, at mild central hypovolemia (i.e., SV=100-80 % of bsln), SVR 
was increased approximately by 10 % while HR remained unaffected. Then, during 
further reduction of SV (i.e., SV=<80 % of bsln), HR increased with decreasing SV 
while SVR remained elevated around 10 % above baseline level. Hence, here we 
show that compensation for mild hypovolemia is a biphasic response in which the 
SVR immediately increases followed by an increase in HR. As HR does not respond 
immediately to a reduction in SV and SVR cannot compensate during further reduction 
of SV, these parameters are suboptimal for monitoring the onset and progression of 
hypovolemia. 
In general, the increased HR and SVR compensated adequately for the decreased 
SV and maintained CO and MAP around baseline level during the entire LBNP protocol. 
It must be noted, however, that cardiovascular collapse is not included in the analysis 
since the aim of the present study was to integratively investigate the sensitivity of 
NIRS to reflect the degree of (compensated) hypovolemia during LBNP. Thus, in this 
early stage of hypovolemia, CO and MAP were maintained near baseline level, but by 
definition, at the moment of collapse, both CO and MAP rapidly decreased (data not 
Figure 3 A) Thenar and forearm tissue oxygen saturation (StO2) and B) thenar and forearm tissue 
hemoglobin index (THI) plotted versus stroke volume (SV). All parameters were normalized and 
expressed as percentage of baseline (bsln). * p<0.05 versus SV=100 % of bsln, # p<0.05 versus 
one SV category higher, and & p<0.05 versus same probe on the thenar. P>0.05 for 15 mm versus 
25 mm.
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shown). However, this study focuses on the early detection of hypovolemia, i.e., when 
hypovolemia is still adequately compensated.  
Earlier studies have demonstrated that during LBNP blood flow in the upper 
body peripheral regions decreases due to vasoconstriction induced by augmented 
muscle sympathetic nerve activity [30] and cardiopulmonary receptor unloading [31]. 
This is supported by our measurement of increased SVR during LBNP. Hansen et 
al. and Hachiya et al. have shown that this LBNP-induced (upper) body peripheral 
vasoconstriction is reflected by forearm NIRS measurements using a 30 mm NIRS 
probe size [9, 32]. Moreover, Fadel et al. showed that during LBNP forearm NIRS 
measurements using a 20 mm NIRS probe size highly correlated with forearm blood 
flow velocity measured by Doppler ultrasound [33]. Reduced forearm blood flow and 
reduced THI result in greater microcirculatory oxygen extraction and thereby reduced 
forearm StO2 [34]. In summary, it is well-established that central hypovolemia leads to 
(upper) body peripheral vasoconstriction and that hypovolemia reflected by forearm 
NIRS measurements. Therefore, NIRS might be suited to monitor the volume status of 
intensive care patients or (post)surgical patients. 
In previous studies, NIRS was used to identify hypoperfusion, predict organ 
dysfunction, and to guide resuscitation in trauma patients [35]. Crookes et al. showed 
that thenar StO2 could reflect severe hypovolemic shock, but could not identify mild 
or moderate shock [36]. Cohn et al. reported no differences in thenar StO2 values 
between trauma patients and healthy volunteers. For this reason, NIRS cannot identify 
hypovolemia directly by assessment of steady-state (or baseline) StO2. However, these 
measurements were all carried out on thenar and no THI values were reported [35-36]. 
Previously, we have found that forearm StO2 is a more sensitive parameter for 
detecting hypovolemia-induced peripheral vasoconstriction compared to thenar 
StO2 [11]. This LBNP study confirms and strengthens our earlier findings. First, 
in a pilot study, we found that forearm StO2 was more responsive to head-up tilt 
compared to thenar StO2 [12]. Second, in a simple study on multi-depth thenar and 
forearm StO2 before and after a posture change, it was shown that forearm StO2 was 
more responsive to the hemodynamic changes associated with the posture change 
compared to thenar StO2, independent of NIRS probing depth, which confirmed the 
findings of the pilot study [11]. Here we measured StO2 and THI with two multi-depth 
NIRS devices on the forearm and thenar simultaneously and again found that forearm 
StO2 and THI were more sensitive to central hypovolemia compared to thenar StO2 
and THI. Although the marginal decrease (2-3 %) from baseline to SV=60-40 % of 
bsln in thenar StO2 is statistically significant, this finding is not (clinically) relevant. 
Forearm StO2, on the other hand, did decrease notably (8-9 %) and approximated the 
decrease in forearm StO2 observed previously (11% at a SV=~40 %) [7,8]. Hence, the 
thenar and forearm NIRS measurements in the present study are comparable to those 
in [7,8], even though different NIRS devices were used. However, as this is the first 
study measuring StO2 and THI simultaneously in the thenar and forearm at multiple 
depths, we have now established that the sensitivity of the NIRS measurements is not 
dependent on probing depth but rather depends on measurement site. This finding 
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rebuts the hypothesis postulated previously that the 15 mm probe size on the forearm 
would be too small to reflect hypovolemia [8]. 
A potential physiological explanation for the difference between the thenar and 
forearm in terms of sensitivity to hypovolemia is that the circulation in the hands 
might be well-preserved during cardiovascular challenges. An example of such a 
phenomenon is cold-induced vasodilation during severe hypothermia, which opens the 
(micro)circulation to the hands in order to prevent cold-induced necrosis and thereby 
increase the chances of survival [37]. However, whether such a response also exists in 
case of hypovolemia remains unknown. Either way, although in the present study we 
could not identify why the forearm microcirculation is more sensitive to changes in 
volume status compared to the thenar microcirculation, we have clearly shown that 
this is indeed the case and that the forearm is a more appropriate measurement site 
for NIRS for monitoring changes in the peripheral microcirculation in response to 
changes in volume status.    
It should be noted, however, that there are some practical considerations regarding 
the use of NIRS in critically ill patients and the extrapolation of the results we present 
here to clinical scenarios. First, in the present study, no severe hypovolemia with 
hypotension or shock was included. However, the main objective was to use NIRS 
to detect hypovolemia in the compensated phase (i.e., with maintained blood 
pressure) and to the test the hypothesis that the sensitivity of NIRS to reflect the 
degree of (compensated) hypovolemia would be affected by the application site and 
probing depth. This we have clearly shown, as differences between NIRS probing 
sites could be detected in this early, compensated phase of central hypovolemia. 
Second, it is important to realize that the NIRS measurements reflect changes in the 
peripheral microcirculatory perfusion and that in the present study, these changes 
were induced by application of LBNP. We anticipate that vasoactive drug-related 
changes in peripheral microcirculatory perfusion would also be detected. However, 
when patients are on vasoactive drugs that prevent the peripheral microcirculation 
to respond to changes in their volume status, NIRS would obviously not be able to 
detect hypovolemia as no changes would occur in the peripheral microcirculation. 
Third, another aspect potentially affecting the detection of hypovolemia using NIRS 
is peripheral edema. During LBNP, no peripheral edema was present. Still, the LBNP-
related central hypovolemia is comparable to fluid loss-related hypovolemia as this 
type of hypovolemia would also decrease stroke volume and lead to the activation 
of compensatory mechanisms such as increased heart rate and systemic vascular 
resistance. Whether the NIRS measurements would be able to reflect the degree of 
hypovolemia in the presence of peripheral edema, however, remains to be established 
as tissue edema limits the oxygen offloading in the microcirculation and might thereby 
keep StO2 artificially high. The THI, in contrast, would probably decrease in case of 
fluid loss-related hypovolemia as the THI is directly related to peripheral vascular tone. 
Fourth, other approaches, such as the assessment of stroke volume variations (SVV) or 
pulse pressure variations (PPV), might also provide information on changes in volume 
status. However, SVV and PPV both focus on the hypovolemia-related changes that 
occur on the arterial side of the circulation and therefore, in contrast to NIRS, do not 
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reflect changes in the adequacy of tissue oxygenation that occur due to hypovolemia. 
Fifth, and final, the changes in observed in StO2 and THI are rather small (i.e., ~8-9 %) 
and might be difficult to detect in clinical practice. Therefore, whether the sensitivity 
of NIRS to detect hypovolemia by could be increased by addition of a dynamic test, 
such as a vascular occlusion test, should be explored [21].     
In conclusion, the application of LBNP results in a significant blood volume shift 
and SV reduction that is countered by an increase in SVR and HR, which adequately 
compensate for the decrease in SV and the maintenance of CO and MAP near baseline 
level. NIRS can be used to detect central hypovolemia and applied on the forearm, 
NIRS is more sensitive to reflect changes in SV than when applied on the thenar. The 
sensitivity of NIRS does not depend on the NIRS probing depth. The present study 
confirms the first part of the hypothesis that application site would affect the sensitivity 
of NIRS and rejects the second part of the hypothesis that probing depth would affect 
the sensitivity of NIRS.
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aBstract
There is little clinical evidence that red blood cell (RBC) transfusions improve oxygen 
availability at the microcirculatory level. We tested the hypotheses that anemia 
in chronically anemic patients with relatively healthy microcirculation would be 
associated with low tissue hemoglobin (Hb) and tissue oxygenation levels and that 
these conditions would be improved after RBC transfusions.
Near-infrared spectroscopy (NIRS) was used to determine tissue oxygen saturation 
(StO2) and tissue Hb index (THI; an index of the amount of Hb in the NIRS measurement 
volume) in the thenar eminence and sublingual tissue before and 30 minutes after RBC 
transfusions in 20 chronically anemic hematology outpatients. Data are presented as 
median (25 % -75 %).
The patients received three (two to three) bags of RBCs in saline-adenine-glucose-
mannitol with an age of 21 (7-21) days, which was infused intravenously at the rate of 
0.7 bag/hr. RBC transfusions significantly increased hematocrit level from 26 % (24-28) 
to 32 % (30-34; p<0.0001), Hb level from 8.2 (7.6-8.9) g/dL to 11.0 (9.9-11.8) g/dL 
(p<0.0001), whole blood viscosity from 3.4 (3.1-3.5) mPa/sec to 4.2 (4.0-4.5)  mPa/sec 
(p<0.0001), thenar StO2 from 81 % (80-84) to 86 % (81-89; p=0.002), thenar THI from 
11.2 (9.3-13.3) AU to 13.7 (9.7-15.3) AU (p=0.024), sublingual StO2 from 86 % (81-89) 
to 91 % (86-92; p<0.0001), and sublingual THI from 15.2 (13.0-17.4) AU to 17.2 (13.5-
19.7) AU (p=0.040).
We conclude that RBC transfusions were successful in improving these variables, 
although anemia in chronically anemic hematology outpatients was not associated 
with low StO2 and THI levels, 
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introduction
The primary goal of red blood cell (RBC) transfusions is to increase hematocrit (Hct) and 
blood hemoglobin (Hb) levels, thereby improving microcirculatory Hb availability and, 
ultimately, tissue oxygenation. To date, only a few clinical studies have investigated 
the effects of RBC transfusions on peripheral microcirculation. In a study by Sakr and 
colleagues [1] in septic patients, no changes were found after RBC transfusions in 
microcirculatory density and perfusion when measured sublingually using orthogonal 
polarization spectral imaging. Similarly, Creteur and colleagues found no effect of RBC 
transfusions on microcirculatory oxygenation in septic and nonseptic intensive care 
patients, as measured in the thenar eminence using near-infrared spectroscopy (NIRS) 
[2]. Contrary to these studies, we recently demonstrated improved microcirculation 
upon RBC transfusion in cardiac surgery patients [3]. The contrasting results of these 
studies may be related either to the impaired microcirculation in septic patients 
compared with cardiac surgery patients or to the fact that intensive care patients are 
chronically (or progressively) anemic, while cardiac surgery patients suffer from a more 
acute onset of anemia [4]. In this respect, it has been shown that chronic anemia 
leads to the development of compensatory mechanisms, such as an increased release 
of oxygen, due to higher levels of 2,3-diphosphoglycerate acid [5]. In this study, 
we focused on the latter factor and investigated the effects of RBC transfusions on 
microcirculatory oxygenation and Hb availability in anemic hematology outpatients, 
a chronically anemic patient group with relatively healthy microcirculation (compared 
with that of sepsis patients). We tested the hypotheses that anemia in these patients 
would be associated with low levels of tissue oxygen saturation (StO2) and a low tissue 
Hb index (THI) and that these conditions would improve after RBC transfusions. The 
THI reflects the amount of Hb in the NIRS measurement volume. This variable depends 
on both the systemic Hb level, which is low because these patients are anemic, and 
the peripheral vascular tone (i.e., vasoconstriction decreases THI and vasodilation 
increases THI). In this light, we expected that, as with the systemic Hb level, THI would 
be low in anemic patients. Because StO2 reflects mainly microcirculatory oxygenation, 
this variable indicates the balance between microcirculatory oxygen delivery and tissue 
oxygen consumption. Hypothesizing that these patients would have a low THI, we also 
expected that the StO2 would be low. In this study, we aimed to identify whether the 
chronic nature of anemia is the limiting factor in the efficacy of RBC transfusions in 
some anemic patient groups.
material and methods
This study protocol was approved by the institutional medical ethics committee of the 
AcademicMedical Center of the University of Amsterdam. Written informed consent 
was obtained from all participating patients. This study was performed in compliance 
with the principles established in the Helsinki Declaration.
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Patients
Anemic hematology outpatients requiring RBC transfusions were considered eligible 
for participation in this study and were recruited during a 2-month period. The threshold 
for transfusion was set at a Hb level of less than 9.6 g/dL according to standard clinical 
practice in the Department of Clinical Hematology of the Academic Medical Center 
and Dutch transfusion guidelines (CBO guidelines 2011, p. 117) [6]. Transfusion was 
stopped after reaching this threshold or after infusion of 3 RBC units. RBC units were 
prepared according to the standards of Sanquin, the Netherlands national blood 
bank. The units contained concentrated RBCs obtained after centrifuging whole blood 
to remove the buffy coat, adding saline-adenine-glucose-mannitol solution, and 
filtering out the white blood cells (WBCs) [6,7]. Upon arrival at the short-stay center 
for RBC transfusions and after a cross-match blood examination, all participants were 
subjected to the same investigational procedures, that is, standard determination of 
venous blood (gas) and hemodynamic variables and NIRS measurements that were 
performed sublingually and in the thenar eminence, as described below. 
nirs
The patients were placed in a semi supine (30° head-up) position in a hospital bed with 
their hands (palm up) and arms passively maintained at heart level. The arm opposite 
to the infusion arm was used in the NIRS measurements. A NIRS device (InSpectra 
650, Hutchinson Technology, Hutchinson, MN) equipped with a 15-mm probe was 
used to measure StO2 (%) and THI (arbitrary units [AU]) noninvasively before and 
30 minutes after blood transfusion in the thenar eminence, as previously described 
[3,8]. For the sublingual NIRS measurements, an identical probe was used, which was 
placed on the sublingual mucosa parallel to the frenulum linguae on the same side 
as the thenar measurements. The spectrometer uses a reflectance mode probe with a 
1.5-mm optical fiber to illuminate tissue and a 0.4-mm optical fiber, which is spaced 15 
mm from the illuminating fiber, to detect backscattered light. The NIRS measurement 
depth is estimated as approximately half of the distance between the illumination and 
detection fibers [9-11]. Both the StO2 and the THI calculations from the NIRS signal 
have been validated by Myers and colleagues [9,12]. 
whole blood viscosity assessment
Whole blood was collected in sterile blood tubes, each of which contained 10 mL of 
blood and 18 mg of K2EDTA, as an anticoagulant. A Couette low-shear viscometer 
(Contraves LS-30, proRheo GmbH, Althengstett, Germany) was used to measure whole 
blood viscosity at shear rates of 0.87, 2.19, 5.49, 10.15, 47.1, and 87/sec, in decreasing 
order [13]. All measurements were performed at a stable temperature of 37°C and 
were completed within 1 hour of the time that the blood sample was collected.
statistical analysis
Statistical analysis was performed using computer software (Prism 5.0, GraphPad 
Software, La Jolla, CA). The Wilcoxon matched-pairs test was used for comparative 
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analysis of data sets obtained before and after RBC transfusion. All data are presented 
as median values followed by the 25 % to 75 % range in parentheses. Differences were 
considered significant at p<0.05.
results
Twenty consecutive anemic clinic outpatients (11 males and 9 females) with various 
hematological malignancies with an age of 65 (60-68, Table 1) years requiring RBC 
transfusions participated in this study. The patients received 3 (2-3) bags of packed 
red blood cells with an age of 21 (7-21) days, which were infused intravenously at the 
rate of 0.7 bags/h. 
Table 1: Patient characteristics.  Data are presented in median (25th-75th) unless indicated otherwise.
demographics
Age 65 (60-68) years
Sex (male:female) 11: 9
underlying disease
Myelodysplastic Syndrome 7 patients
Myelofibrosis 4 patients
Multiple Myeloma 3 patients
Acute Myeloid Leukemia 2 patients
Chronic Myeloid Leukemia 1 patient
Chronic Lymphocytic Leukemia 1 patient
Metastasis bleeding 1 patient
Non-Hodgkin Lymphoma 1 patient
transfusion characteristics
Number of RBC 3 (2-3) bags
Age of transfused blood 21 (7-21) days
All NIRS measurements were performed successfully and without any inconvenience 
or discomfort to the patients. Hct, Hb, whole blood viscosity, and hemodynamic 
variables before and 30 minutes after RBC transfusions are presented in Table 2. 
RBC transfusions increased the Hct from 26 % (24-28) to 32 % (30-35; p<0.0001), 
Hb from 8.2 (7.6-8.9) g/dL to 11.0 (9.8-11.8) g/dL (p<0.0001; Fig. 1A), and whole blood 
viscosity from 3.4 (3.1-3.5) mPa/sec to 4.2 (4.0-4.5) mPa/sec (p<0.0001). Mean arterial 
pressure (MAP) increased from 84 (77-92) mmHg to 94 (84-107) mmHg (p=0.006), and 
heart rate decreased slightly from 82 (71-91) bpm to 78 (71-87) bpm (p=0.088; Fig. 1B).
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Table 2: Blood and hemodynamic parameters
Before transfusion after transfusion
Parameter Unit Median 25th 75th Median 25th 75th p-value Normal range
Hematocrit [%] 26 24 28 32 30 35 <0.0001 36 – 51 
Hemoglobin [g/dL] 8.2 7.6 8.9 11.0 9.8 11.8 <0.0001 12.1 – 17.7
Blood viscosity [mPa∙s] 3.4 3.1 3.5 4.2 4.0 4.5 <0.0001 3.0 – 4.0
Systolic BP [mmHg] 135 116 147 145 120 158 0.067 90 – 140
Diastolic BP [mmHg] 72 61 80 77 73 85 0.009 60 – 80
MAP [mmHg] 84 77 91 94 84 107 0.006 70 – 90
Heart rate [bpm] 82 71 91 78 71 87 0.088 60 – 90
Temperature [oC] 36.9 37.7 37.1 37.1 36.9 37.6 0.008 35.5 – 37.5
Figure 1. A) Hemoglobin (Hb; g/dL) and hematocrit (Hct; %) levels before and after transfusion, 
B) mean arterial pressure (MAP; mmHg) and heart rate (HR; beats per minute) before and after 
transfusion, C) thenar tissue oxygenation (StO2; %) and tissue hemoglobin index (THI; AU) before 
and after transfusion, and D) sublingual tissue oxygenation (StO2; %) and tissue hemoglobin 
index (THI; AU) before and after transfusion. BTx=blood transfusion; *indicates p<0.05 versus 
before BTx.
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After the RBC transfusion, the thenar (Fig. 1C) and sublingual (Fig. 1D) StO2 and 
THI increased significantly. The thenar StO2 and THI increased from 81 % (80-84) to 
86 % (81-89; p=0.002) and from 11.2 (9.3-13.3) AU to 13.7 (9.7-15.3) AU (p=0.024), 
respectively. The sublingual StO2 and THI increased from 86 % (81-89) to 91 % (86-92; 
p<0.0001) and from 15.2 (13.0-17.4) AU to 17.2 (13.5-19.7) AU (p=0.040), respectively. 
discussion
In this study, we investigated the effects of RBC transfusions on microcirculatory 
oxygenation in chronically anemic patients with relatively healthy microcirculation. 
We hypothesized that anemia in these patients would be associated with low StO2 
and Hb availability (THI), which would increase after the RBC transfusion. This is an 
important issue because studies addressing the efficacy of RBC transfusion at the 
microcirculatory level have only concerned critically ill patients and showed little or 
no effect of RBC transfusions on microcirculation [1,2]. In this study, we demonstrate 
that, although anemia in chronically anemic outpatients was not associated with low 
StO2 and THI levels, RBC transfusions were successful in improving these conditions.
Although RBC transfusions successfully improved such conditions as Hct and Hb 
levels, whole blood viscosity, and MAP [2,3,14,15], the efficacy of RBC transfusions in 
improving microcirculation and, ultimately, tissue oxygenation is poorly understood. 
Recently, microcirculation has gained increasing attention as an independently 
functioning physiological compartment in which the roles of the glycocalyx, RBCs, 
and WBCs are shifted from passive components to active mediators [2,3].
Blood transfusion practice and policies have been a topic of debate since several 
large clinical studies demonstrated the potentially harmful effects of allogeneic blood 
transfusions, such as infection transmission, immunosuppression, inflammation and 
coagulation in the lung, and atrial fibrillation [16-19]. These studies concluded that 
restrictive transfusion thresholds and regimens contribute to better clinical outcomes. 
Whether the adverse effects of blood transfusions are due to the composition of the 
transfused blood (e.g., leukoreduced vs. leukodepleted blood) or other factors (e.g., 
age of the transfused blood) remains elusive. Nevertheless, the decision of whether to 
give a blood transfusion remains a consideration of the beneficial effects of transfusion, 
for example, increasing the systemic oxygen-carrying capacity, microcirculation, and 
ultimately, tissue oxygenation versus the adverse effects of transfusion. In this line of 
reasoning, blood transfusion not only improves systemic Hct but also increases whole 
blood viscosity, as we have shown here. This increase in viscosity, in turn, stimulates 
microvascular perfusion as a result of shear stress-induced vasodilation, as described 
by Lenz and colleagues [20].
To date, only a few studies have investigated the direct effects of RBC transfusions 
on peripheral microcirculation [1-3,21], and only two studies have shown a beneficial 
effect of RBC transfusions on microcirculation in adults [3] and anemic preterm infants 
[21]. The contrasting results of these studies might be explained by the studied patient 
populations because the studies showing no effect of RBC transfusions were carried 
out in (septic) intensive care patients in whom the microcirculation is significantly 
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impaired with endothelial dysfunction and abnormal endogenous RBCs [1,2,4,22]. 
This microcirculatory dysfunction is much less prevalent in surgical patients [3] and 
preterm infants [21] possibly explaining the discrepancy between the different studies.
In addition to differences in the microcirculation caused by systemic inflammatory 
responses, the chronic nature of anemia also may limit the efficacy of RBC transfusions 
on microcirculatory oxygenation. Therefore, we studied the effects of RBC transfusions 
on microcirculatory oxygenation in anemic outpatients with a hematologic malignancy 
but with relatively healthy microcirculation (compared with that of sepsis patients). We 
showed that the microcirculatory oxygenation and Hb availability were slightly but 
significantly increased after RBC transfusions. Although the THI and StO2 increases 
were modest, this was a highly consistent finding. The sensitivity of both variables 
to anemia and blood transfusion has been questioned [2]. Here we show that blood 
transfusion did significantly improve StO2 and THI, but whether the small changes in 
THI or StO2 are of any clinical significance remains to be established. In intensive care 
patients, blood transfusion did not improve these NIRS variables. Thus, in this study, 
we have found that there is a difference in response to blood transfusion between 
intensive care patients and hematology outpatients. However, the mechanisms 
preventing blood transfusions from effectively reaching the microcirculation in 
intensive care patients are yet unknown.
This study reports on the use of NIRS on multiple locations to examine the effect of 
RBC transfusions and introduces the sublingual site for NIRS measurements. Although 
multisite NIRS measurements have been described before [8,23,24], analysis of 
sublingual tissue to examine the effects of RBC transfusions on microcirculation was 
not performed previously. A study by Yuruk and coworkers [3] applied a spectroscopic 
technique similar to the NIRS technique used here; however, due to the different 
wavelength range and probe spacing used in their study, a much smaller measurement 
volume was captured. Furthermore, to our knowledge, THI has not been used to 
describe the effects of RBC transfusions at the microcirculatory level. Because THI 
reflects microcirculatory oxygen-carrying capacity in tissue, this variable is important 
in studying the effects of RBC transfusions. Previously, NIRS has been employed to 
identify hypoperfusion and to guide resuscitation in trauma patients [25,26]. Cohn 
and coworkers reported no differences in StO2 measurements in the thenar between 
trauma patients and healthy volunteers [25]. Crookes and coworkers showed that 
thenar StO2 values could reflect severe hypovolemic shock, but could not identify mild 
or moderate shock [26]. Furthermore, studies in healthy volunteers have also shown 
that StO2 and THI respond poorly to changes in volume status [23,27]. In one study, 
500 mL of blood each was donated by healthy volunteers, and no significant changes 
in StO2 were observed [27]. In another study on healthy volunteers subjected to lower-
body negative pressure (a model in which application of a vacuum to the lower body 
shifts blood from the upper to the lower body, creating central hypovolemia), StO2 
and THI levels were shown to decrease only slightly [23]. Altogether, it seems that 
moderate changes in patient volume changes are poorly reflected by peripherally 
measured StO2 and THI levels.
Although the development of NIRS has recently opened the field of bedside 
monitoring of tissue oxygenation (StO2) and Hb content (THI) at the microcirculatory 
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level in a variety of patient populations, the interpretation of the measurements 
should be done with great care. NIRS has been used for the detection of sepsis and 
as a predictor of patient outcomes [28-30]. NIRS has, moreover, been employed in 
trauma patients to identify tissue hypoperfusion and to guide resuscitation [25,26]. 
However, the relative contribution of the arterioles, capillaries, and venules to the 
NIRS measurement is unknown, which impedes the full physiological interpretation of 
the StO2 and THI values in separate microvascular compartments. Furthermore, the 
NIRS technology is not able to measure flow, which further limits the interpretation of 
the measurements because flow is a major determinant of tissue oxygenation. Another 
important consideration is the interpretation of THI, which does not reflect only 
systemic Hct and Hb levels but also depends on the peripheral (micro)vascular tone 
[31]. Nonetheless, although baseline StO2 and THI levels in our anemic outpatients 
were within the normal range [8,23], the values associated with both variables 
increased after RBC transfusions, indicating that transfusions can effectively improve 
microcirculatory oxygenation in outpatients with hematologic malignancies. 
A possible limitation of our study may be that we selected anemic outpatients 
with various hematologic malignancies, meaning that we cannot exclude the influence 
of different forms of therapy before this study, such as erythropoietin and high-dose 
chemotherapy, which may have affected microcirculation. However, since the baseline 
microcirculatory oxygenation appeared to be within the normal range and none of the 
patients was treated with chemotherapy at the time of the study, we consider this effect 
to be minor. Furthermore, for this study, a relatively high Hb threshold was applied 
compared with other anemic patient groups. However, according to Dutch guidelines 
and the transfusion policy of the Department of Clinical Hematology, this relatively 
old patient group receives RBC transfusions at an Hb level of less than 9.6 g/dL [6]. 
Although the threshold of 9.6 g/dL was used here, the mean Hb concentration before 
transfusion in this study was 8.2 g/dL, which is considerably lower. In contrast with 
thresholds for platelet transfusions, there are no prospective comparative trials that 
have established the optimal Hb concentration in this specific patient group. However, 
the transfusions have been carried out according to current clinical standards in the 
Netherlands and, therefore, we chose to use this threshold. We expect that the slight 
(but highly consistent) increase in StO2 and THI levels observed in this study will be 
more extensive when a lower transfusion threshold is applied.
In conclusion, we demonstrated that, although anemia in chronically anemic 
hematology outpatients was not associated with low StO2 and THI levels, RBC 
transfusions were successful in increasing the values associated with these variables. 
We also showed that the chronic nature of anemia is not the limiting factor in the 
efficacy of RBC transfusions at the microcirculatory level in some anemic patient groups.
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Throughout history, blood circulation in the human body has drawn a lot of attention, 
which was further encouraged with the observations and publications of William Harvey, 
Marcello Malpighi, and James Blundell. Technological advancements led to new 
discoveries and enabled the development of monitoring tools. As part of the circulation, 
the microcirculation is the most important system for the exchange of oxygen, carbon 
dioxide, and nutrients. The microcirculation comprises blood vessels with a diameter 
< 100 µm, i.e. arterioles, capillaries, and venules. Monitoring the microcirculation has 
demonstrated to provide valuable prognostic information on outcome of patients. 
To study the effects of hypovolemia on the microcirculation isolated from the other 
potentially confounding factors occurring in critically ill patients, we have developed a 
model in which lower body negative pressure (LBNP) is applied in healthy volunteers 
to create central hypovolemia, which allows elaborate microcirculatory studies in which 
volume status can be modulated in a controlled fashion.
LBNP-induced progressive hypovolemia is associated with a decrease in stroke 
volume (SV) triggering compensatory mechanisms and therefore, reliable continuous 
measurements of SV are of key importance to assess the effects of application of 
LBNP. When SV decreases, compensatory mechanisms, such as increased heart 
rate (HR) and systemic vascular resistance (SVR) will maintain cardiac output (CO). 
In Chapter I continuous beat-to-beat contour analysis (Nexfin) was compared with 
inert gas rebreathing and respired gas analysis. Nineteen healthy male volunteers, 
who completed a medical questionnaire, were subjected to bicycle ergometry testing 
with increasing workloads. Cardiac output, HR, and SV were determined using Nexfin, 
inert gas rebreathing, and respired gas analysis. Rebreathing tests were performed 
at baseline and at HR = 150 bpm, while Nexfin results were recorded continuously. 
Respired gas analysis was performed in a maximal exercise protocol in a subgroup. 
The CO values derived from the Nexfin- and inert gas rebreathing methods were 
well correlated and the limits of agreement were 30.3 %. Nexfin- and respired gas 
analysis-derived CO values correlated even better. At rest, the rebreathing maneuver 
increased HR by 13 bpm, SV remained unaffected, while CO increased by 1.0 L/
min. Rebreathing did not affect these parameters during exercise. In conclusion, 
Nexfin continuous beat-to-beat pulse contour analysis is an appropriate method for 
noninvasive assessment of CO during exercise.
Increasing SVR early in the onset of hypovolemia results in reduced peripheral 
perfusion. To investigate the ability of the pulse oximeter-derived Peripheral Perfusion 
Index (PPI) to reflect early peripheral vasoconstriction during progressive hypovolemia, 
we applied lower body negative pressure (LBNP) in healthy volunteers until onset of 
cardiovascular collapse in Chapter II. Twenty-five healthy volunteers were subjected 
to a stepwise LBNP protocol and SV, heart rate, blood pressure, SVR, and CO were 
recorded using volume clamp finger plethysmography. The PPI assessment was done 
by pulse oximetry. During the first LBNP step, SV decreased, while heart rate remained 
unaltered. In contrast, SVR increased and PPI decreased, reflecting vasoconstriction 
and decreased peripheral flow. During further progression of LBNP, both SV and HR 
changed proportionally to the applied negative pressure, whereas SVR and PPI remained 
unaltered around the LBNP=-20 mmHg level throughout the rest of the protocol. As 
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a result of adequately functioning compensatory mechanisms, BP and CO did not change 
significantly throughout the experiment. In conclusion, LBNP results in a decrease in 
SV and an increase in HR and SVR. The latter two can be successfully monitored using 
the applied pulse oximeter and the PPI can be used as a complementary hemodynamic 
monitoring technique for the early detection of central hypovolemia. 
In Chapter III we investigated the microcirculatory alterations during hypovolemia 
in more detail. The objective of the study described in this chapter was to test 
the hypothesis that controlled, adequately compensated, central hypovolemia in 
subjects with intact autoregulation would be associated with decreased peripheral 
microcirculatory diffusion and convection properties and, consequently, decreased 
tissue oxygen carrying capacity and tissue oxygenation. Furthermore, we evaluated 
the impact of hypovolemia-induced microcirculatory alterations on resting tissue 
oxygen consumption. To this end, twenty-four subjects were subjected to a 
progressive LBNP protocol of which fourteen reached the end of the protocol. At 
baseline and at LBNP=-60 mmHg, sidestream dark field images of the sublingual 
microcirculation were acquired to measure microvascular density and perfusion. 
Near-infrared spectroscopy (NIRS) was used to measure thenar and forearm tissue 
oxygenation (StO2) and hemoglobin content (THI) and a vascular occlusion test (VOT) 
was performed to assess resting tissue oxygen consumption rate. Application of LBNP 
resulted in a significantly decreased microvascular density (oxygen diffusion) and 
perfusion (oxygen convection), significantly decreased THI and StO2 parameters, and 
an unaltered resting tissue oxygen consumption rate. In conclusion, SDF imaging in 
combination with NIRS is associated with decreased microcirculatory diffusion and 
convection properties and, consequently, decreased tissue oxygen carrying capacity 
(THI) and tissue oxygenation (StO2) in subjects with intact autoregulation during 
controlled, adequately compensated, central hypovolemia. Furthermore, using a 
VOT we found that resting tissue oxygen consumption remained unaltered under 
conditions of adequately compensated central hypovolemia.
We further explored the use of NIRS during progressive hypovolemia by testing the 
hypothesis that the sensitivity to reflect the degree of (compensated) hypovolemia is 
affected by the NIRS application site and probing depth in Chapter IV. Therefore, we 
simultaneously applied multi-site (thenar and forearm) and multi-depth NIRS in LBNP. 
Twenty-four healthy male volunteers were subjected to a LBNP protocol and SV and 
HR were measured using volume-clamp finger plethysmography. The StO2 and THI 
results of the thenar and the forearm were compared and the shift of blood volume 
towards the lower extremities was monitored by calf THI and the thoracic fluid content 
(TFC; bioreactance monitoring). Application of LBNP resulted in a significant reduction 
in stroke volume which was accompanied by a reduction in forearm StO2 and THI. 
Furthermore, calf THI increased and TFC decreased, which confirmed the occurrence 
of hypovolemia due to a shift of fluid to the lower body, which was compensated 
by an increased HR and SVR. In summary, NIRS can be used to detect changes in 
StO2 and THI consequent to central hypovolemia. Forearm NIRS measurements are 
more sensitive to hypovolemia than thenar NIRS measurements, verifying the first part 
of the hypothesis. The sensitivity of NIRS measurements does not depend on NIRS 
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probing depth, rejecting the second part of the hypothesis. The LBNP-induced shift of 
blood volume is demonstrated by the decreased THI in the forearm and an increased 
THI in the calf.
In Chapter V we studied the clinical applicability of NIRS and translated the findings 
of previous studies into clinical practice. Little clinical evidence is available that red 
blood cell (RBC) transfusions improve oxygen availability at the microcirculatory level. 
We tested the hypotheses that anemia in chronically anemic patients with a relatively 
healthy microcirculation would be associated with low tissue hemoglobin and tissue 
oxygenation levels and that these conditions would be improved following RBC 
transfusions. Near-infrared spectroscopy was used to determine StO2 and THI in the 
thenar eminence and sublingual tissue prior to and 30 minutes after RBC transfusions 
in twenty chronically anemic hematology outpatients. RBC transfusions significantly 
increased hematocrit, hemoglobin, and whole blood viscosity levels. Thenar and 
sublingual StO2 and THI were not decreased at the baseline measurements, but 
increased after RBC transfusion. We conclude that anemia in chronically anemic 
hematology outpatients was not associated with low StO2 and THI levels, yet RBC 
transfusions were successful in improving these parameters.
The research described in this thesis demonstrates the ability of currently available 
techniques to monitor microcirculatory alterations in subjects with hypovolemia 
and anemia. Microcirculatory parameters showed (early) alterations in response to 
hypovolemia, but appeared within the normal range in chronic anemic outpatients. 
Further research is required to use the described modalities to guide microcirculatory-
targeted therapies.

samenvatting en conclusies 
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De bloedcirculatie in het menselijk lichaam heeft in de loop van de geschiedenis veel 
aandacht gehad. Deze belangstelling werd aangewakkerd door de observaties en 
publicaties van William Harvey, Marcello Malpighi en James Blundell. Technologische 
innovaties leidden tot nieuwe inzichten en maakten de ontwikkeling van 
meetinstrumenten mogelijk. Als onderdeel van de bloedcirculatie is de microcirculatie 
het belangrijkste onderdeel voor de uitwisseling van zuurstof, koolstofdioxide en 
voedingsstoffen. De microcirculatie bestaat uit vaten met een diameter kleiner dan 
100 µm: de arteriolen, venulen en capillairen. Het is reeds aangetoond dat observatie 
van de microcirculatie waardevolle informatie over de prognose en klinische uitkomst 
van patiënten kan verschaffen. Om de effecten van hypovolemie op de microcirculatie 
zonder vertroebelende factoren te bestuderen, is er een model ontwikkeld waarin 
lower body negative pressure (LBNP) op gezonde vrijwilligers wordt toegepast. Op 
deze manier wordt centrale hypovolemie gecreëerd en kunnen microcirculaire studies 
naar volume-veranderingen op een gecontroleerde manier worden verricht.
De hypovolemie die door LBNP wordt geïnduceerd gaat gepaard met een 
afname in het slagvolume en dit leidt weer tot compensatiemechanismen, zoals 
een verhoogde hartslag en toegenomen vasculaire weerstand. De aanpassingen 
leiden ertoe dat de hoeveelheid bloed die per minuut het hart uitgepompt wordt, 
constant blijft. In Hoofdstuk I is de continue pulse contour analyse (Nexfin) met inert 
gas rebreathing en een ventilatie analyse methode vergeleken. Negentien gezonde 
mannelijke vrijwilligers hebben een medische vragenlijst ingevuld en een fietstest 
gedaan. Hartslag, slagvolume en hartminuutvolume werden met behulp van Nexfin, 
inert gas rebreathing en de ventilatie analyse methode gemeten. Rebreathing 
metingen werden voor de start van het protocol gedaan en bij een hartslag 150 
bpm. De Nexfin waarden werden continu gemeten. De ventilatie analyse methode 
werd in het kader van een ander protocol uitgevoerd, waarin een subgroep van de 
gezonde vrijwilligers tot maximale inspanning ging en zowel de Nexfin resultaten als 
de waarden van de ventilatie analyse methode continu geregistreerd werden. De 
resultaten van Nexfin en inert gas rebreathing correleerden goed met elkaar en de 
grenzen van overeenkomst (limits of agreement) waren 30,3 %. Nexfin en de ventilatie 
analyse methode correleerden nog beter. De rebreathing methode bleek de hartslag 
met 13 bpm te verhogen, het hartminuutvolume met 1,0 L/min, maar veranderde 
het slagvolume niet. Tijdens inspanning bleven deze parameters ongewijzigd. We 
concluderen dat Nexfin pulse contour analyse een geschikte methode is voor het 
noninvasief meten van hartminuutvolume tijdens inspanning.
In Hoofdstuk II hebben we LBNP toegepast als model voor centrale hypovolemie 
om de geschiktheid van de Peripheral Perfusion Index (PPI) te bepalen voor het 
vroegtijdig detecteren van vasoconstrictie tijdens (progressieve) hypovolemie bij 
vrijwilligers. Tijdens het LBNP protocol werden slagvolume, hartslag, bloeddruk 
en hartminuutvolume gemeten met volume clamp plethysmografie. De PPI werd 
bepaald met behulp van een puls oximeter. Tijdens de eerste LBNP stap nam het 
slagvolume af, maar veranderde de hartslagfrequentie niet. De vasculaire weerstand 
en de PPI veranderden wel en zijn een indicatie voor vasoconstrictie en afgenomen 
bloedcirculatie. Tijdens verdere LBNP blootstelling veranderden het slagvolume en 
108
de hartslag proportioneel met de negatieve druk, maar de vasculaire weerstand en 
PPI bleven op hetzelfde niveau als bij de inductie van LBNP. De bloeddruk en het 
hartminuutvolume bleven door adequaat functionerende compensatie mechanismen 
ongewijzigd. Concluderend leidt het LBNP protocol tot een afname in slagvolume 
en een toename in zowel hartslag als vasculaire weerstand. De hartslag en 
vasculaire weerstand kunnen met een pulse oximeter gemeten worden en PPI kan 
als aanvullende hemodynamische observatie-techniek voor de vroege detectie van 
centrale hypovolemie functioneren. 
In Hoofdstuk III zijn de microcirculaire veranderingen tijdens hypovolemie in 
meer detail onderzocht. Het doel van de studie was om de hypothese te testen dat 
gecontroleerde, adequaat gecompenseerde, centrale hypovolemie in personen met 
intacte autoregulatie leidt tot een afname van perifere microcirculaire diffusie en 
convectie. De verwachting was dat hierdoor de hoeveelheid beschikbare zuurstof in 
het weefsel en de weefsel-saturatie afgenomen was. Verder hebben we het effect 
van hypovolemie-geïnduceerde microcirculaire veranderingen op zuurstofconsumptie 
in weefsel onderzocht. Vierentwintig personen werden aan een LBNP protocol 
onderworpen, waarvan veertien de laatste stap van dit protocol bereikten. Voor 
de start van het protocol en bij LBNP=-60 mmHg werden sidestream dark field 
beelden van de sublinguale microcirculatie gemaakt om de microvasculaire diffusie- 
en convectieparameters te bepalen. Near-infrared spectroscopy (NIRS) werd in 
thenar en onderarm toegepast om de weefsel saturatie vast te stellen en er werd 
een vasculaire occlusie test gedaan om het zuurstofverbruik in rust te bepalen. 
We hebben gevonden dat LBNP leidt tot significant afgenomen microvasculaire 
dichtheid (diffusie) en perfusie (convectie), significant afgenomen NIRS waarden en 
een onveranderde zuurstofconsumptie. Concluderend hebben we aangetoond dat 
centrale hypovolemie gepaard gaat met afgenomen SDF en NIRS parameters, maar 
dat de zuurstofconsumptie onveranderd blijft. 
Het gebruik van NIRS tijdens toenemende hypovolemie werd in meer detail 
onderzocht in Hoofdstuk IV. Hierin werd de hypothese getest dat de sensitiviteit om 
hypovolemie te detecteren door de plek waar de NIRS probe bevestigd wordt en de 
diepte van het NIRS signaal beïnvloed wordt. Om dit te evalueren zijn er simultaan 
multi-site (thenar en onderarm) en multi-depth NIRS metingen tijdens LBNP gedaan. 
Vierentwintig personen participeerden in een LBNP protocol, waarin slagvolume en 
hartslag met volume clamp plethysmografie gemeten werden. Vervolgens werden de 
NIRS resultaten met elkaar vergeleken. De verplaatsing van het bloedvolume naar 
het onderlichaam werd gemonitord met behulp van een NIRS sensor op de kuit en 
met het meten van de thoraxvochtvolume trend (Thoracic Fluid Content; bioreactance 
monitoring). De belangrijkste bevinding was dat de afname van NIRS parameters, die 
in de onderarm het meest sensitief was, niet bepaald werd door de probing depth. 
Het LBNP model functioneerde adequaat, aangezien het slagvolume afnam, het 
NIRS signaal op de kuit eveneens veranderde en daarnaast de thoracic fluid content 
verminderde. Als reactie hierop namen de vasculaire weerstand en de hartslag toe om 
zo het hartminuutvolume te compenseren. Concluderend kan NIRS gebruikt worden 
om veranderingen ten gevolge van centrale hypovolemie te detecteren. De metingen 
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op de onderarm zijn meer sensitief dan de metingen op de thenar en bevestigen 
het eerste deel van de hypothese. De sensitiviteit wordt echter niet bepaald door de 
diepte van het NIRS signaal en verwerpt dus het tweede deel van de hypothese. 
In Hoofdstuk V is de klinische toepasbaarheid van NIRS bestudeerd en zijn enkele 
bevindingen uit eerdere hoofdstukken vertaald naar de patiëntenzorg. Er is weinig 
klinisch bewijs beschikbaar dat bloedtransfusies de beschikbaarheid van zuurstof op 
microcirculair niveau verbeteren. We hebben de hypothesen getest dat anemie in 
patiënten met chronische anemie en een relatief gezonde microcirculatie gepaard 
gaan met relatief lage weefsel hemoglobine en oxygenatie waarden. We verwachtten 
dat transfusies deze parameters verbeteren. NIRS parameters werden op de thenar 
en in sublinguaal weefsel zowel voor transfusie als 30 minuten na transfusie gemeten 
bij 20 hematologie patiënten met chronische anemie. De transfusies leidden tot 
significant hogere hematocriet-, hemoglobine- en viscositeitwaarden. Zowel thenar 
als sublinguale NIRS resultaten waren voor transfusie niet verlaagd, maar stegen 
wel na transfusie. Zodoende concluderen wij dat chronische anemie in hematologie 
patiënten niet gepaard gaat met lage NIRS parameters, maar dat bloedtransfusies wel 
succesvol waren om deze parameters te verbeteren. 
Het onderzoek beschreven in dit proefschrift laat de mogelijkheden van de huidige 
beschikbare technieken zien om microcirculaire veranderingen ten gevolge van 
hypovolemie en anemie te observeren. De microcirculatie demonstreert veranderingen 
ten gevolge van hypovolemie in een vroege fase, maar met betrekking tot chronisch 
anemische hematologie patiënten bevonden de resultaten zich binnen normaal 
waarden. Verder onderzoek is vereist om het gebruik van de onderzochte methoden 
te kunnen richten op toepassingen bij microcirculatie-geöriënteerde therapieën. 
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